Taking the guesswork out of sales, predictive analytics could lead way to improved pharma rep decisions | https://www.veeva.com/media/taking-the-guesswork-out-of-sales-predictive-analytics-could-lead-way-to-improved-pharma-rep-decisions/ | 2015-07-24|http://www.fiercepharmamarketing.com/story/taking-guesswork-out-sales-predictive-analytics-could-lead-way-improved-pha/2015-06-17 | | Automated suggestions can help pharma reps who are searching for the next step in the sales process. But more than just automatic tips, emerging intelligent data-backed suggestions can transform inexperienced or underperforming reps using the mold of a pharma’s top performers. That’s the pitch from cloud-based software vendor Veeva, which recently announced it’s adding data-informed suggestions to its CRM system in November. Called CRM Suggestions, the feature is free to system users and goes hand-in-hand with the announcement of Veeva’s Data Science Partner program naming ZS Associates and Aktana as the first partners. Those two data science engines will be pre-integrated into CRM Suggestions to make it easier to get started.|Automated suggestions can help pharma reps who are searching for the next step in the sales process. But more than just automatic tips, emerging intelligent data-backed suggestions can transform inexperienced or underperforming reps using the mold of a pharma’s top performers.
Orchestrating Key Stakeholder Engagement for Launch Success | https://www.veeva.com/media/orchestrating-key-stakeholder-engagement-for-launch-success/ | 2015-07-22|http://www.mmm-online.com/orchestrating-key-stakeholder-engagement-for-launch-success/printarticle/427666/ | | Every successful business has a mechanism in place to learn from what is and is not working. New technology is available today that allows companies to automate customer data capture and disseminate it across teams that can learn from the insights and change direction mid-launch. With modern technology, it is now possible to use metrics to correlate with performance and change direction.|
How to Do Digital: 5 Steps to Kick Start Dynamic Digital Initiatives | https://www.veeva.com/media/how-to-do-digital-5-steps-to-kick-start-dynamic-digital-initiatives/ | 2015-06-29|http://www.pm360online.com/how-to-do-digital-5-steps-to-kick-start-dynamic-digital-initiatives/ | | Everyone in the life sciences industry talks about how vital it is to integrate digital into commercial strategies in order to more efficiently target audiences, engage in relevant conversations, and improve conversion. The question is: How?|
RIM Convergence: Getting Ahead of Change | https://www.veeva.com/media/rim-convergence-getting-ahead-of-change/ | 2015-06-25|http://www.pharmaceuticalonline.com/doc/regulatory-information-management-rim-getting-ahead-of-change-0001 | | Any change to producing or selling a product creates an enormous ripple effect, triggering an assembly line of manual data and document checking, emails and meetings, content authoring, and submission planning. The pain and inefficiency involved in managing change can be attributed to three key disconnects: disconnected systems, disconnects between headquarters and affiliates/distributors, and disconnects between business documents and data. By focusing RIM initiatives on convergence, companies get the visibility they need to move quickly and accurately when responding to product changes.|
Five of the World’s Top 20 Pharmaceutical Companies Standardize on Veeva Vault eTMF to Manage Clinical Trial Documents Globally | https://www.veeva.com/media/five-of-the-worlds-top-20-pharmaceutical-companies-standardize-on-veeva-vault-etmf-to-manage-clinical-trial-documents-globally/ | 2015-06-25|http://www.pharmamanufacturing.com/vendors/products/2015/veeva-vault-etmf/ | | In the face of increasing clinical trial cost and complexity and changing regulatory guidelines, life sciences companies are turning to cloud-based Veeva Vault eTMF to improve clinical trial master file (TMF) timeliness, completeness, and inspection readiness. In just over a year, five of the world’s top 20 pharmaceutical companies have standardized on Veeva Vault eTMF, joining more than 50 Vault eTMF customers – from emerging biotechs to CROs and large pharmas – gaining better access, visibility, and control over clinical trial content and processes.|
One Step Closer to Paperless | https://www.veeva.com/media/one-step-closer-to-paperless/ | 2015-06-19|http://www.appliedclinicaltrialsonline.com/one-step-closer-paperless | | Today, Veeva Systems unveiled the results of its 2015 Paperless TMF Survey: Annual Report. The survey is in its second year, and as Jennifer Goldsmith, vice president of Veeva Vault, told Applied Clinical Trials, it was interesting and significant to report on the year-over-year results.|
Electronic Processes Increasingly Replacing Paper In Clinical Trials | https://www.veeva.com/media/survey-electronic-processes-increasingly-replacing-paper-in-clinical-trials/ | 2015-06-18|http://www.clinicalleader.com/doc/survey-electronic-processes-increasingly-replacing-paper-in-clinical-trials-0001 | | Clinical Leader analyzes the results from the Veeva 2015 Paperless TMF Survey: Annual Report. Read what they had to say about the industry moving towards a paperless trial master file.|
Veeva Systems Wants to Give Pharma Reps ‘Suggestions’ | https://www.veeva.com/media/veeva-systems-wants-to-give-pharma-reps-suggestions/ | 2015-06-17|http://pharmaceuticalcommerce.com/latest_news?articleid=27568 | |
Salesforce.com Inc. CRM +2.40% pioneered the cloud-software business and is valued at almost $40 billion. Now a second wave of more specialized online software companies is starting to take off and command rich multibillion-dollar valuations that may be hard to sustain. The companies have unfamiliar names like Veeva Systems Inc., VEEV -0.79% Cvent Inc., CVT -1.34% and DocuSign Inc., and are tackling specific industries such as health care and hospitality or slices of the market such as marketing and project management. “The market is large enough that you can sell into one vertical,” said Bryan Schreier, a partner at Sequoia Capital, which has financed cloud software companies Dropbox Inc. and RingCentral Inc., RNG +2.04% among others. “These companies have a long way to grow.” The rise of niche providers could crimp the growth of big software makers such as Oracle Corp. ORCL +2.05% , SAP AG SAP.XE +0.37% , Salesforce.com and International Business Machines Corp. IBM +0.62% , while presenting a larger threat to company-built software or programs from lower-tier players that have been slow to shift to the Internet. “We believe there is a great white-space opportunity in delivering apps and infrastructure to specific industries and verticals,” wrote Wells Fargo Securities analyst Jason Maynard in a recent report naming “industry clouds” as one of the top 10 software trends of the year. Unlike Salesforce.com and Workday Inc., WDAY +4.02% which offer one-size-fits-all software, some of the specialized providers are profitable and have better margins since they don’t have to spend as much on sales and marketing. But some customers warn of potential problems with future growth, saying smaller companies providing industry-specific software could have trouble meeting the needs of global clients. Historically, investors shied away from financing niche players because they thought the markets were too small. But in recent years these companies have taken off as the technology has become easier to use and cheaper, broadband Internet service has become pervasive, and customers are more open to using cloud software. Their business models are also attractive to investors, requiring customers to pay a low but recurring monthly fee. Last year, a dozen cloud software companies such as pharmaceutical software maker Veeva Systems and event-planning software maker Cvent held public offerings, posting an average return of about 50%, according to IPO investment adviser Renaissance Capital. These companies are trading at ultra-high valuations. Veeva Systems, which is valued at more than $4 billion, trades at about 158 times expected earnings for 2015, while Cvent and its near-$2 billion market value trades at nearly 400 times expected earnings. Salesforce, meanwhile, has a multiple of around 90 times expected earnings. Several more cloud software companies are in the IPO pipeline, including payroll processor Paylocity Corp., banking-services provider Q2 Holdings Inc. and global trading software maker Amber Road Inc. Another startup, electronic signature software company DocuSign, said Tuesday it raised $85 million in a deal that values the company at about $1.6 billion, a person familiar with the matter said. Some of the companies are turning a profit, unlike the heavy losses from Salesforce.com and Workday, which spend roughly 40% to 50% of their revenue on sales and marketing to grab customers. The specialized cloud companies are able to spend less on marketing because it can be more targeted, and word-of-mouth recommendations travel faster in single industries, say executives. RealPage Inc. a maker of cloud software to help manage rental properties, earned $21 million on $377 in revenue in 2013. Sales and marketing consumed about 25% of its sales. Veeva, which sells marketing software for pharmaceutical and biotechnology companies, posted a $24 million profit on $210 million in sales in the fiscal year ended Jan. 31, according to its earnings report released Tuesday. Sales and marketing expenses accounted for only 20% of Veeva’s revenue. Seven-year-old Veeva is winning over big customers such as drug maker Mylan Inc., MYL +0.29% which last fall began a global rollout of some Veeva applications. The software will help thousands of Mylan salespeople to manage relations with their customers in a highly regulated industry, replacing manual processes, custom-built and packaged programs used all over the company with one system accessible over the Web. Michael Smith, chief information officer of Mylan, said the company chose Veeva over programs from Oracle, SAP, Salesforce.com, and Microsoft Corp., older companies that make software for a range of industries and business tasks. He said it would take 18 to 24 months to introduce Veeva around the world, compared to four to six years for packaged software run on its own computers. Since Veeva concentrates on life sciences, it has been able to build numerous unique features, such as giving salespeople the ability to quickly look up the drug reimbursement policies of dozens of insurers, or displaying which states prohibit nurses from receiving drug samples. “We are very close to our customers,” said Veeva Systems CEO Peter Gassner. Marty Hoski, global manager of travel and meeting operations for SAT provider Educational Testing Service, is a big fan of Cvent’s software. He chose it over programs from Oracle and SignUp4, another specialized provider. Mr. Hoski said SignUp4 was “limited in what it could do” and “time, scope and cost was through the roof to get an Oracle module in place that would have had very limited functionality.” SignUp4 and Oracle declined to comment. A couple of years ago, Mr. Hoski had little control over the $40 million the company spent annually on meetings. Administrative assistants would sign pricey contracts for venues. Invites went out with typos and bad grammar. “We had no idea what they were doing,” he said. Now, using Cvent, Mr. Hoski’s meeting planners can bid out a deal to its network of suppliers, execute the contract, and manage the marketing of the event all from a Web browser. The additional oversight and leverage provided by Cvent software saves the company about $8 million a year, he said, while improving the quality of the events.
|Salesforce.com Inc. pioneered the cloud-software business and is valued at almost $40 billion. Now a second wave of more specialized online software companies is starting to take off and command rich multibillion-dollar valuations that may be hard to sustain.
Digital Think Tank: A Work in Progress | https://www.veeva.com/media/digital-think-tank/ | 2014-02-28|http://www.mmm-online.com/digital-think-tank-a-work-in-progress/article/334775/ | | Paul Shawah, Veeva’s vice president of commercial strategy, offers elevator insights on the state of digital pharma–the ups, the downs and how to get to the next level. What has encouraged you most in the past 12 months in digital pharma? In what areas is progress being made? In a word… “speed.” Pharma is generally perceived as slow-moving, but digital capabilities are rapidly emerging—and the industry’s willingness to adopt these tools is growing. Companies are motivated to leverage digital innovations that enhance customer engagement. One example is personalized communications with HCPs using tools like email. Long considered taboo, email is an exciting capability companies are embracing thanks to solutions that remove the compliance risk. And what continues to frustrate you? Where are the major challenges and roadblocks, and what needs to be done to overcome them? Even with the industry’s newfound willingness to test digital capabilities, learn and scale, there remain organizational barriers every step of the way. The “innovator’s dilemma” is alive and well—it’s hard to change processes and selling models that proved successful in the not-so-distant past. To fully go “digital” and successfully navigate through the increased pace of business that digital makes possible, organizational structure, processes and commercial models must be reinvented. What will be the most important digital pharma trend(s) in the next 12 months? By far, the most important trend in digital for the life sciences industry will not be a new technology, but rather…a new mindset—a commitment to making digital communications an integrated part of the promotional mix. Optimal results only occur when digital is strategically combined and aligned with the activities of the field force. Next year, the industry will look for ways to identify and orchestrate the best promotional mix—digital, face-to-face, email—for each customer.|Paul Shawah, Veeva’s vice president of commercial strategy, offers elevator insights on the state of digital pharma–the ups, the downs and how to get to the next level. What has encouraged you most in the past 12 months in digital pharma? In what areas is progress being made? In a word… “speed.” Pharma is generally perceived as slow-moving, but digital capabilities are rapidly emerging—and the industry’s willingness to adopt these tools is growing.
The Top 10 Customer Relationship Management Services | https://www.veeva.com/media/the-top-10-customer-relationship-management-services/ | 2014-02-21|http://venturebeat.com/2014/02/11/top-10-crm-services/ | | Businesses grow when they maintain healthy relationships with their customers. For your local deli, that might mean a quick chat to go with your pastrami sandwich. But for companies with more complex operations, customer relationship management (CRM) software is often essential. Every CRM solution comes in a different flavor — and at a different price. There’s CRM software that enables employees to create, assign, and manage requests made by customers — so when you call your cable company, for example, a representative can pull up your file to view your prior service history and log new information. CRM sales software provides companies with a suite of tools to manage the entire sales process, from initial lead qualification to opportunity management, forecasting, and eventually deal closure. CRM marketing systems can track campaigns over various channels, such as traditional mail and phone efforts, email, search, and social media.|
2013 IPO Scorecard: Here are the 27 Winners, Losers of Silicon Valley, Bay Area | https://www.veeva.com/media/2013-ipo-scorecard-here-are-the-27-winners-losers-of-silicon-valley-bay-area/ | 2014-02-20|http://www.bizjournals.com/sanjose/news/2013/12/13/2013-ipo-winners-losers-in-silicon.html?s=image_gallery | | Up 65%: Veeva Systems, led by CEO Peter Gassner, raised $261 million in an October IPO that debuted on the NYSE with a more than 80 percent jump in price. The IPO price was $20 and it closed on Dec. 19 at $32.94. The Pleasanton-based life-sciences software company’s biggest backer is Emergence Capital Partners.|
The True Power of Cloud Software | https://www.veeva.com/media/the-true-power-of-cloud-software/ | 2014-02-14|http://www.cioreview.com/magazine/The-True-Power-of-Cloud-Software-UCIB929108054.html | | Organizations are rapidly moving from pre-internet client-server software to more flexible cloud-based solutions. The basic advantages of cloud-based software are well known. Companies can deploy the software in a matter of weeks or months rather than years. They can pay as they go and get the latest updates quickly and continuously. And cloud software enables companies to respond and adapt to business issues that arise unexpectedly.|
Can Veeva Systems’ Software Keep Luring Big Pharma? | https://www.veeva.com/media/can-veeva-systems-software-keep-luring-big-pharma/ | 2014-01-06|http://news.investors.com/business-the-new-america/021715-739578-veeva-is-primed-to-keep-up-share-gains-in-life-science-crm.htm?ref=HPLNews | | It takes some doing for a small fry to make a dent in a market ruled by industry big shots. But that’s what software service provider Veeva Systems (VEEV) has done since making its market debut in October 2013, as it’s taken share from larger rivals that were using older technology. Veeva, founded in 2007, specializes in providing cloud-based software to the life sciences industry.|
Stop Pouting About Tech’s Next Big Thing, It’s Here | https://www.veeva.com/media/stop-pouting-about-techs-next-big-thing-its-here/ | 2014-01-03| | | 2013 Was Not a Lost Year. Plus, Three Tech Trends to Watch in 2014 Wall Street Journal – December 31, 2013
It’s easy to get jaded when you cover the technology industry. Silicon Valley’s giants are constantly belching wisps of marshmallow-thick hype, and any reporter looking to cover the beat has to be constantly on guard against unproven claims about this or that algorithmically-abetted amazing advance. And another thing: We’re witnessing the dawn of a new paradigm in machine-human cooperation Everett Collection So when Christopher Mims of Quartz recently declared 2013 to be a “lost year for tech”—one in which, he says, the industry produced nothing of great value—I could see where he was coming from. I feel the same way some days; when I’m covering some new me-too social-media product or a great new way to target ads, I hang my head in despair. But then I read a couple of rebuttals to Mims by Daring Fireball’s John Gruber and Om Malik, of Gigaom. They argued that the industry’s biggest advances have occurred beneath the media’s radar, and that the industry, as a whole, is anything but stagnant. I side with these more positive takes. Here’s my roundup of reasons to break out of your tech funk and be optimistic about tech in 2014. First, stop clamoring for the “next big thing.” Were you disappointed, once again, that Apple AAPL +0.39% didn’t release something amazing and new this year—a TV or a smartwatch, say? Were you bummed that there were few revolutionary features on the latest smartphones? Have you concluded that the tech business is boring, that there isn’t any more innovation, that we live in uninteresting times? I, too, constantly yearn for mind-blowing new tech. But I’ve been getting tired of the claim that just because we haven’t seen something on the order of the smartphone or tablet in the last few years, the tech industry can no longer innovate. The problem with this argument is that the touchscreen smartphone (and its cousin the tablet) was a singularly novel, industry-shattering device, and we’re unlikely to see anything as groundbreaking in a generation. The smartphone and the tablet *are* the next big things, and we act like spoiled children when we claim that they somehow aren’t enough. Most future advances will simply be improvements or expansions on these basic technologies—ways to make smartphones and tablets cheaper, more powerful, smaller, lighter, and to let them control and connect with an ever-larger slice of our lives. In 2013 we saw several such innovations. Google’s GOOG +1.66% Motorola MSI +0.22% subsidiary released a really good phone, the Moto G, that sells for $199 without a contract—the first of several devices that will radically expand access to mobile phones. Meanwhile Apple’s top-of-the-line devices came with an incredible processor, the A7, which proved that mobile devices can approach the power of desktop-class PCs. I was blown away, too, by the growth of apps that are now rewiring our worlds—apps such as ride-sharing service Uber or the robotic slot-car racer Anki Drive, which show the potential for our phones to transform the physical world. As the analyst Benedict Evans has argued, the true revolution in mobile computing is one of scale; we’re going from an Internet controlled by PCs to one controlled by three billion to five billion phones. No device on the horizon—not the long-awaited TV made by Apple, not Google Glass, not a smartwatch—will be as exciting as what smartphones and tablets hold in store for us. So let’s stop yearning for new stuff just for novelty’s sake. The next big thing is already here, it’s in your pocket, and it’s incredible. Second, privacy is no longer an afterthought. I’ve already argued that the disappearing-message app Snapchat was the most interesting technology of 2013 because it paved the way for services that don’t save all our data by default. The larger message of Snapchat, though, is that privacy isn’t dead. For years, tech giants have given lip service to privacy. “It’s very important to us!” they insist while slurping up mountains of your data. But the industry hasn’t spent much time looking at privacy as a place for innovation, as a feature that users will care about when they choose apps or services. Thanks to Snapchat, revelations about the National Security Agency, and an increased fear of living in a panopticon, that will thankfully begin to change in 2014. Watch for an avalanche of apps that take privacy seriously—whether they delete data by default, keep your data local, or limit the scope of their sharing. Third, enterprise tech is interesting, finally. For years, business software was a dead-end for innovation, dominated as it was by Microsoft, MSFT +0.54% Oracle, ORCL +1.91% and other entrenched incumbents. Now that’s changing. In 2013 several alternatives rose to challenge old-school business tech—like Quip, a clever new word-processing app, or Box’s collaboration software, Box Notes—and I suspect this trend will continue this year. One enterprise advance I’m looking forward to: The rise of companies looking to bring cloud-based services to specific, specialized markets—also known as “vertical software-as-a-service” businesses. I’m talking about firms like Veeva Systems, VEEV -0.67% which makes a cloud-based sales tool for the health care industry, and which successfully went public in the fall. Watch for other startups aimed at specific industries—law firms, hospitality, health care—to get really big, without anyone noticing, in 2014. Last but not least, robots aren’t necessarily coming for your job. It’s been a cliché in the Valley for years that machines will replace humans across a wide variety of job types. But while artificial intelligence is still advancing at a furious pace, I was thrilled that AI is augmenting, rather than superseding, humans. Look how Redfin used tech to create better real-estate agents rather than replace them, or how the app Duolingocrowdsources human intelligence to produce better translations than machines are capable of. I think we’re witnessing the dawn of a new paradigm in machine-human cooperation: Combining machine intelligence with biological intelligence will always trump one or the other. Machines make us better, and we make machines better. There’s still hope for us. Welcome to the bionic future. Do you have any to add? I’d love to hear from you about the best and worst tech trends of the year.|It’s easy to get jaded when you cover the technology industry. Silicon Valley’s giants are constantly belching wisps of marshmallow-thick hype, and any reporter looking to cover the beat has to be constantly on guard against unproven claims about this or that algorithmically-abetted amazing advance. Dan Goldsmith Named Innovative Person by PM360 | https://www.veeva.com/media/dan-goldsmith-named-innovative-person-by-pm360/ | 2013-12-11|http://www.pm360online.com/innovators-people-2/?GTTabs=4 | | Dan Goldsmith, general manager, has been named an Innovative Person and a Data Management Master in PM360’s Innovations issue. Dan focuses his efforts on developing Veeva Network, Veeva’s most recent product offering and the industry’s first and only cloud-based customer data master solution combining data, software and stewardship services.|Dan Goldsmith, general manager, has been named an Innovative Person and a Data Management Master in PM360’s Innovations issue. Veeva Systems’ CEO on Why Pharma Needs his Cloud Software | https://www.veeva.com/media/veeva-systems-ceo-on-why-pharma-needs-his-cloud-software/ | 2013-11-06|http://www.forbes.com/sites/kerryadolan/2013/11/06/veeva-systems-ceo-on-why-pharma-needs-his-cloud-software/ | | FORBES – Peter Gassner has spent his career in the world of software and relational databases, working at IBM IBM and then PeopleSoft. He witnessed the promise of cloud software while working at Salesforce.com CRM. His vision, though, was to target an industry in need of specialized software housed in the cloud. So he left Salesforce and cofounded Veeva Systems in 2007, building software catered to pharmaceutical and life sciences firms.|Veeva Systems is at the heart of two explosive megatrends: the cloud and life sciences. So it should be no surprise that the company had little trouble with its IPO. In today’s trading, the shares are up a sizzling 80%. “It looks like you’re trying to use word on an iPad” | https://www.veeva.com/media/it-looks-like-youre-trying-to-use-word-on-an-ipad-2/ | 2013-10-31|http://www.businessweek.com/magazine/it-looks-like-youre-trying-to-use-word-on-an-ipad-01192012.html | | In this article from Bloomberg Businessweek, Matt Wallach is interviewed on iRep and the iPad’s importance to the global pharma industry.| Veeva CEO: ‘Customer Dissatisfaction is My Opportunity’ | https://www.veeva.com/media/veeva-ceo-customer-dissatisfaction-is-my-opportunity/ | 2013-10-23|http://www.forbes.com/sites/tomtaulli/2013/10/16/veeva-ceo-customer-dissatisfaction-is-my-opportunity/?partner=yahootix | | FORBES – Veeva Systems is at the heart of two explosive megatrends: the cloud and life sciences. So it should be no surprise that the company had little trouble with its IPO. In today’s trading, the shares are up a sizzling 80%. Yet Veeva has done something else that is remarkable: the company is not only growing quickly but is also profitable. In fact, the company has generated more operating cash flows – in the past year – then it has raised in overall funding.|Veeva Systems is at the heart of two explosive megatrends: the cloud and life sciences. So it should be no surprise that the company had little trouble with its IPO. In today’s trading, the shares are up a sizzling 80%. Veeva Systems CEO: We’re Focused on the Life Sciences | https://www.veeva.com/media/fox-business-veeva-systems-ceo-were-focused-on-the-life-sciences/ | 2013-10-22|http://video.foxbusiness.com/v/2759475063001/veeva-systems-ceo-were-focused-on-the-life-sciences/ | | Fox Business — Veeva Systems CEO Peter Gassner on the future of the cloud computing company.| Moving the Life Sciences Industry to the Cloud | https://www.veeva.com/media/bloomberg-moving-the-life-sciences-industry-to-the-cloud/ | 2013-10-21|http://www.bloomberg.com/video/moving-the-life-sciences-industry-to-the-cloud-u2qa~IVeT3Sg0eNe1CaG5g.html | | Bloomberg — Peter Gassner, co-founder and CEO of Veeva Systems, discusses the company’s cloud-based software for the global life sciences industry. He speaks with Cory Johnson on Bloomberg Television’s “Bloomberg West.” |Peter Gassner, co-founder and CEO of Veeva Systems, discusses the company’s cloud-based software for the global life sciences industry. He speaks with Cory Johnson on Bloomberg Television’s “Bloomberg West.” CNBC Squawk on the Street | https://www.veeva.com/media/cnbc-squawk-on-the-street/ | 2013-10-20| | | CNBC Squawk on the Street — “Veeva listing on the big board today, after pricing at $20 above the range, Peter Gassner is the CEO …” |CNBC — Veeva Systems may not get the sexy headlines of, say, a Twitter or Facebook, but it sure has investors’ attention. On Heels of Veeva Systems’ Mega IPO, a look at its Philly Ties and Vision for Life Sciences IT | https://www.veeva.com/media/it-looks-like-youre-trying-to-use-word-on-an-ipad/ | 2013-10-18|http://www.phillytechnews.net/2013/10/on-heels-of-veeva-systems-mega-ipo-look.html | | This article from Philly Tech News covers the Veeva IPO and the launch of Veeva Network.| Veeva Systems IPO Shows Updraft in Cloud Business | https://www.veeva.com/media/veeva-systems-ipo-shows-updraft-in-cloud-business/ | 2013-10-16|http://www.cnbc.com/id/101118773?__source=msn%7Cmoney%7Cheadline%7Cheadline%7Cstory%7C&par=msn | | CNBC — Veeva Systems may not get the sexy headlines of, say, a Twitter or Facebook, but it sure has investors’ attention. In its initial public offering Wednesday, the cloud-based software company saw its shares, which had been priced at $20, soar as high as $39.64. The stock closed at $37.16 a share. The Pleasanton, Calif.-based company is part of two major trends that investors can’t seem to get enough: 1) It’s a cloud service provider for life sciences companies, including big names such as Pfizer, Eli Lilly, and Novartis. 2) It has been profitable for the past three years and in the past year generated more operating cash flow than it raised in funding.|CNBC — Veeva Systems may not get the sexy headlines of, say, a Twitter or Facebook, but it sure has investors’ attention. Veeva CEO: We Were Never Going to Delay IPO | https://www.veeva.com/media/veeva-ceo-we-were-never-going-to-delay-ipo/ | 2013-10-16|http://finance.fortune.cnn.com/2013/10/16/veeva-ceo-we-were-never-going-to-delay-ipo/?source=yahoo_quote | | FORTUNE — Veeva Systems, a provider of cloud-based CRM and content management solutions for the life sciences industry, will begin trading shares on the NYSE today, after raising around $261 million in its IPO. The Pleasanton, Calif.-based priced its shares at $20 a piece, compared to an original target range of just $12-$14, and is now valued at more than $2.4 billion. I guess that’s what happens when your company not only is growing at more than 100% year-over-year, but also is profitable on just $10 million in VC funding.|FORTUNE — Veeva Systems, a provider of cloud-based CRM and content management solutions for the life sciences industry, will begin trading shares on the NYSE today, after raising around $261 million in its IPO. Veeva IPO Defies Jitters Over US economy | https://www.veeva.com/media/veeva-ipo-defies-jitters-over-u-s-economy/ | 2013-10-14|http://247wallst.com/apps-software/2013/10/16/veeva-ipo-defies-jitters-over-u-s-economy/ | | 24/7 Wall St — Veeva Systems Inc. (NYSE: VEEV), a California-based company that makes cloud software solutions for the life sciences industry, held its initial public offering (IPO) Wednesday morning among a swirl of uncertainty about the U.S. economy. Investors have put aside any worries, though, driving the stock to a more than 80% gain in the first hour of trading.| Veeva Systems Stock Soars on Debut | https://www.veeva.com/media/veeva-systems-stock-soars-on-debut/ | 2013-10-14|http://bigstory.ap.org/article/veeva-systems-stock-soars-debut | | AP – The Big Story — NEW YORK (AP) — Shares of Veeva Systems Inc. nearly doubled in their trading debut Wednesday after the cloud-based software company raised about $261 million in its initial public offering. Veeva Systems, which is based in Pleasanton, Calif., makes cloud software for pharmaceutical companies and other life science businesses that helps them manage customers and increase productivity. The programs are hosted on remote servers, often called the “cloud.” That means that businesses don’t need to install and run software in-house, saving on the costs of running their own hardware.| Veeva Systems Stock Soars on Debut | https://www.veeva.com/media/huffington-post-veeva-systems-stock-soars-on-debut/ | 2013-10-14|http://www.huffingtonpost.com/huff-wires/20131016/us–veeva-systems-ipo/?utm_hp_ref=media&ir=media | | Huffington Post — NEW YORK — NEW YORK (AP) — Shares of Veeva Systems Inc. are soaring in their trading debut Wednesday after the cloud-based software company raised about $261 million in its initial public offering.| Pharmaceutical Companies Finding Cloud Comfort Level | https://www.veeva.com/media/medcity-news-pharmaceutical-companies-finding-cloud-comfort-level/ | 2013-10-14|http://www.medcitynews.com/2013/10/pharmaceutical-companies-finding-cloud-comfort-level/ | | MedCity News — If any sector gets more flack for being slow to adopt innovative IT than healthcare, it’s the pharmaceutical industry. Yet, as companies have been forced to find new ways to streamline work flows and reduce costs, many are finding that some cloud-based tools could help. Cloud software solutions are taking on several different tasks in the pharmaceutical and medical device industry. It can mean improving the quality of data for sales forces and providing practical ways for clinical trial site managers to communicate across a wide geographic divide. It’s also making it easier for companies to merge without the problems that invariably arise when data between disparate computer systems is aggregated. But looking ahead, there are also some intriguing applications that involve combining the cloud with big data from public and private sources and applying analytics.| Eli Lilly’s Veeva Bags OPPI Sales Force Excellence Award 2013 | https://www.veeva.com/media/eli-lillys-veeva-bags-oppi-sales-force-excellence-award-2013/ | 2013-09-30|http://www.pharmabiz.com/NewsDetails.aspx?aid=77898&sid=2 | | PharmaBiz.com — To promote excellence in pharmaceutical selling in 2012, Eli Lilly and Company – India, the leading innovation based pharmaceutical player, has won the OPPI Sales Force Excellence Award 2013 for its project Veeva which aimed at delivering unparalleled customer experience by empowering the sales force.|To promote excellence in pharmaceutical selling in 2012, Eli Lilly and Company – India, the leading innovation based pharmaceutical player, has won the OPPI Sales Force Excellence Award 2013 for its project Veeva which aimed at delivering unparalleled customer experience by empowering the sales force. The Quiet Successes that Drive Silicon Valley | https://www.veeva.com/media/siliconvalley/ | 2013-08-16|http://finance.fortune.cnn.com/2013/08/13/the-quiet-successes-that-drive-silicon-valley/ | | FORTUNE — Salesforce.com recently announced the acquisition of EdgeSpring, an emerging player in the business intelligence/analytics market. It was an amazing outcome for the company’s two founders, employees and investors (Lightspeed and Kleiner Perkins). So why didn’t you hear about it? Because the founders want it that way. They represent Quiet Success. And – despite what you may have been led to believe – it happens every day in Silicon Valley.|Salesforce.com recently announced the acquisition of EdgeSpring, an emerging player in the business intelligence/analytics market. It was an amazing outcome for the company’s two founders, employees and investors (Lightspeed and Kleiner Perkins). Quarterbacking Multi-Channel Interactions | https://www.veeva.com/media/quarterbacking-multi-channel-interactions/ | 2013-08-12|http://www.pm360online.com/quarterbacking-multi-channel-interactions/ | | It’s the fourth quarter, a tie game with 45 seconds left on the clock and third down. Suddenly, the defense blitzes the quarterback. Does he pass downfield or carry the ball? Does he stick with the play or change directions and hand-off? Only the quarterback can make this game-time decision. He is the only player who can see the entire field, and therefore, who has all of the information needed to coordinate the best course of action by picking from a variety of plays. But in the pharmaceutical industry, the sales rep—the quarterback of the customer relationship—doesn’t have a full view of the field. He only has partial visibility, seeing just a slice of the customer interactions. These reps rarely see the interactions that marketing, for example, has with a customer—and vice versa.|It’s the fourth quarter, a tie game with 45 seconds left on the clock and third down. Suddenly, the defense blitzes the quarterback. Does he pass downfield or carry the ball? Does he stick with the play or change directions and hand-off? Sunshine Act open payment requirements to spur cloud-provider growth and M&A interest | https://www.veeva.com/media/sunshine-act/ | 2013-08-01|http://www.ft.com/cms/s/2/4663f4da-f926-11e2-a6ef-00144feabdc0.html#axzz2aXblC21M | | Cloud-based healthcare provider (HCP) data service companies are expected to see a jump in business growth as well as M&A, investor and partnership interest because of new open payment rules under the US Sunshine Act, experts told BioPharm Insight. The legislation – otherwise known as the Physician Payments Sunshine Act – is set to come into force on 1 August 2013. It requires pharmaceutical and medical device companies to publicly list all payments to or money spent on physicians and other HCPs greater than USD 10. The information will be available on the public database Centers for Medicare & Medicaid Services (CMS). Failure to comply could lead to charges of up to USD 100,000 per incidence.| Veeva Buys AdvantageMS, Building Out its Foundation for Healthcare-Provider Master Data | https://www.veeva.com/media/healthcare-provider-master-data/ | 2013-07-15|http://pharmaceuticalcommerce.com/index.php?pg=latest_news&articleid=26906&keyword=Veeva-AdvantageMS-Goldsmith-CRM-master%20data | | Acquisition brings millions of provider listings into the Veeva Network, along with validation services and territory-alignment software. Veeva (Pleasanton, CA), a leading CRM vendor serving the life sciences industry exclusively, has followed through on the promise it made at its annual customer meeting in May, buying AdvantageMS (Fort Washington, PA) for an undisclosed sum. The company had announced Veeva Network at that meeting, which will include master-data management and compliance services when it goes live later this year. When Veeva announced this service, it said that the Network will be enhanced by pooling (pending client approval) the HCP data of the customers of its CRM solutions.|Acquisition brings millions of provider listings into the Veeva Network, along with validation services and territory-alignment software. After 42 Years…Email Finally Clicks in the Pharmaceutical Industry | https://www.veeva.com/media/email-in-the-pharma-industry/ | 2013-06-26|http://www.drugs.com/news/after-42-years-email-finally-clicks-pharmaceutical-industry-45501.html | | After just four-plus decades, email has finally clicked in the pharmaceutical industry – and not a moment too soon. As technology advances allow life science companies to evolve their communications strategies with compliant email, sales reps can now increase and improve the quality of customer interactions, reach more low-access healthcare practitioners globally and deliver more relevant drug information — all without increasing the size of the sales force.|Top 10 Ways to Secure a Competitive Edge with Compliant Email Communications. After just four-plus decades, email has finally clicked in the pharmaceutical industry – and not a moment too soon. iPad vs. Windows 8 Surface: Which is Better for Pharma? | https://www.veeva.com/media/pharma-ipad-windows-8/ | 2013-06-25|http://www.pm360online.com/ipad-vs-windows-8-surface-which-is-better-for-pharma/ | | The iPad vs. the Surface Pro. iOS vs. Windows 8. Apple vs. Microsoft. Have these two tech heavyweights elicited an internal debate within pharma companies over which device is better for their sales teams or is the choice a foregone conclusion? After all, pharma has already heavily adopted the iPad and they are not alone. On the vendor-side, Veeva Systems, a leader in cloud-based software for the global life sciences industry, recently released their CLM and CRM mobile offerings for Windows 8, after already having the offerings available for iOS devices. Their goal was to accommodate the client no matter their preference. “A number of our customers have started to explore the move to a single device and are evaluating the potential impact to their businesses,” says Paul Shawah, VP of Commercial Strategy for Veeva Systems. “But whether or not this is the right move depends entirely on each organization. The benefits and trade-offs are specific to their unique needs and environments.”| Veeva Introduces CRM for Windows 8, Protected E-mail Service and a Bid for Master-Data Management | https://www.veeva.com/media/veeva-introduces-crm-for-windows-8-protected-e-mail-service-and-a-bid-for-master-data-management/ | 2013-05-10|http://www.pharmaceuticalcommerce.com/index.php?pg=latest_news&articleid=26860&keyword= | | Veeva (Pleasanton, CA), which originated the popular cloud-based CRM and iRep platforms for life sciences field sales forces several years ago, has upped the ante with its rollout of a set of new products and business services, announced at its annual users group meeting (Philadelphia, May 6-8).| California-Based Cloud Pharma CRM & CMS Vendor Veeva Systems May Seek IPO | https://www.veeva.com/media/california-based-cloud-pharma-crm-cms-vendor-veeva-systems-may-seek-ipo-2/ | 2013-03-14|http://www.phillytechnews.net/2013/03/california-based-cloud-pharma-crm-cms.html | | Veeva Systems, a cloud CRM and CMS vendor that has rapidly emerged as a leader in serving the pharmaceutical industry, may be considering an IPO, according to a Bloomberg report.| Into the Cloud: New Technology Blowing in Big Benefits to Regulated Content Management in Life Sciences | https://www.veeva.com/media/into-the-cloud-new-technology-blowing-in-big-benefits-to-regulated-content-management-in-life-sciences/ | 2013-03-04|/wp-content/uploads/2013/05/Advise-February-2013-Global-Forum-2.pdf | | For more than two decades, life sciences organizations have purchased, configured and deployed a series of ever-expanding and complex content management systems. These tools continue to tack on new capabilities, but they have failed to fundamentally change to meet the new business challenges facing the life sciences market: greater collaboration, fast-paced globalization, increasing compliance and a stronger focus on cost reduction. Cloud computing may be the key. Read how the cloud enables life sciences companies to meet the needs of the current business climate: to collaborate closely, connect globally, comply swiftly and manage costs effectively.| B2B Investor Gordon Ritter Excited by VC Market’s Pivot | https://www.veeva.com/media/b2b-investor-gordon-ritter-vc-markets-pivot/ | 2013-02-26|http://m.bizjournals.com/sanjose/news/2013/02/25/b2b-investor-gordon-ritter-excited-by.html?r=full | | This will be the year of the enterprise. Enterprise application and infrastructure companies are the most popular and powerful business models that the public markets are going to see this year.| Vertical is the New Horizontal: How the Cloud Makes Domain Expertise More Valuable in the Enterprise | https://www.veeva.com/media/vertical-is-the-new-horizontal-how-the-cloud-makes-domain-expertise-more-valuable-in-the-enterprise/ | 2012-07-30|http://techcrunch.com/2012/07/28/vertical-is-the-new-horizontal-how-the-cloud-makes-domain-expertise-more-valuable-in-the-enterprise/ | | In the days before the cloud, on-premise software providers that focused on selling into a vertical market were considered second-class citizens to the “big guns” selling into the broader horizontal marketplace. The real “win”—in market share, wallet share and ultimately, profits—was the broadest approach. The notion of specializing in solutions that serve a market niche or specific industry was considered limited unless it was just the start of something more horizontal. However, with the advent of the SaaS model, the tables have turned. Focusing on niche verticals or specific functional areas may be one of the most successful strategies of the enterprise cloud software era.| Veeva Named to Business Insider’s List of 25 Next Big Enterprise Startups | https://www.veeva.com/media/veeva-named-to-business-insiders-list-of-25-next-big-enterprise-startups/ | 2012-07-26|http://www.businessinsider.com/the-hottest-enterprise-startups-that-venture-capitals-say-they-love-2012-7#veeva-systems-giving-a-regulated-industry-a-great-cloud-service-22 | | If there’s one crowd of people who know about hot startups, it’s the venture capitalists who fund them. Read this article to review the results of Business Insider’s informal survey of a handful of top enterprise VCs to find out which startups they are most excited about.| Cloud Rains Startups | https://www.veeva.com/media/cloud-rains-startups/ | 2012-07-10|/wp-content/uploads/2012/07/SanFranciscoBT_Cloud_Rains_Startups.pdf | | Companies float high on Salesforce technology as salesforce.com makes space on it’s cloud. Read this article about leading organizations – including Veeva – that use Force.com technology to help make their solutions successful.| Did Veeva Vault Just Make Regulated Content Management Systems Sexy? | https://www.veeva.com/media/did-veeva-vault-just-make-regulated-content-management-systems-sexy-2/ | 2012-07-06|http://www.cmswire.com/cms/customer-experience/did-veeva-vault-just-make-regulated-content-management-systems-sexy-016417.php | | Content Management Systems at Life Sciences companies typically don’t have many fans and are rarely seen as beautiful. Veeva Systems is out to change that. Regulatory CMSs in the Life Sciences Industry are seen as an ugly, but necessary, evil because without them companies can’t bring new drugs to market, comply with FDA and ICH regulations, or minimize their chances of going to jail for non-compliance. That being said, why would a hot, happening software company, like five-year old Veeva Systems, and a group of seasoned Regulatory Life Sciences and Web CMS/CRM experts want to enter that business? Read on to find out!| mHealth + HTML5 = Pharma in 2012 | https://www.veeva.com/media/mhealth-html5-pharma-in-2012/ | 2012-03-20|/wp-content/uploads/2012/03/mHealth-+-HTML5pharma-in-2012-Full-Article.pdf | | The technology is already in place; now pharma marketers will focus on enhancing behavioral integration and improving a patient’s mHealth experiences in 2012. Hear what Matt Wallach, Veeva co-founder and chief strategy officer and Jennifer Goldsmith, vice president, Veeva Vault have to say in this insightful article.| Veeva Adds Sample and Promotion Ordering to its Cloud-Based CRM | https://www.veeva.com/media/veeva-adds-sample-and-promotion-ordering-to-its-cloud-based-crm/ | 2012-03-01|http://www.pharmaceuticalcommerce.com/index.php?pg=top_news&articleid=26488&keyword=Veeva-CRM-cloud-iPad-Shawah | | Announces more contract wins; integration with other software platforms in sales force automation To hear Veeva’s VP of product marketing, Paul Shawah, tell it, Veeva (Pleasanton, CA) is now in a position to deliver a steady stream of enhancements, based mostly on customer demand and the attention span of its programmers. The latest: sample and promotional item ordering. “We already have such sample-management functions as electronic signature capture and inventory management; now sales reps can put in orders directly from Veeva CRM, and avoid the inconvenience of going to a sample-ordering portal and rekeying data,” he says. […]| As Business Software Moves to Cloud, Emergence Capital Closes Third Fund at $250M | https://www.veeva.com/media/as-business-software-moves-to-cloud-emergence-capital-closes-third-fund-at-250m/ | 2012-03-01|http://blogs.wsj.com/venturecapital/2012/02/29/as-business-software-moves-to-cloud-emergence-capital-closes-third-fund-at-250m/ | | Ten years ago, the founders of San Mateo, Calif.-based venture firm Emergence Capital Partners made a bet that business software would move to the cloud. Instead of loading software onto local machines, the firm figured, businesses and their employees would access it through a Web browser and get automatic updates sent from outside servers. And instead of paying for it in one big chunk, businesses would pay a monthly fee and could cancel the obligation at any time […]| iPad helps Apple Succeed in Business World | https://www.veeva.com/media/ipad-helps-apple-succeed-in-business-world/ | 2012-02-07|http://www.sfgate.com/cgi-bin/article.cgi?f=/c/a/2012/02/01/BUJ61N0VBN.DTL | | Even as Amazon’s Kindle Fire and other tablets play catch-up in the consumer market, the iPad faces little competition among corporations such as financial services and pharmaceutical firms. Apple’s iPhone, meanwhile, is the top-selling smart phone, forcing businesses to accommodate workers who use it. That has helped set the stage for Apple’s Mac computer to make its own inroads in the corporate world. “We haven’t seen a single pharma deploy on anything but the iPad,” said Matt Wallach, co-founder of Veeva Systems, a Pleasanton maker of sales software for drug companies. “I’ve seen a lot of devices come and go over the years. Nothing touches the speed of adoption of the iPad.”| Apple Infiltrates $3.8 Trillion Market with iPad: Tech | https://www.veeva.com/media/apple-infiltrates-3-8-trillion-market-with-ipad-tech/ | 2012-02-06|http://www.bloomberg.com/news/2012-02-01/apple-invades-3-8t-workplace-market-with-ipad.html | | Apple Inc. (AAPL), without much effort on its part, is making rapid headway in selling to corporations. After years of being the also-ran to Microsoft Corp. (MSFT) in the workplace, Apple has seen its iPad become a standard business tool. “We haven’t seen a single pharma deploy on anything but the iPad,” said Matt Wallach, co-founder of Veeva Systems Inc., a Pleasanton, California-based maker of sales software for drug companies. “I’ve seen a lot of devices come and go over the years. Nothing touches the speed of adoption of the iPad.”| RIM’s New CEO is Staying the Course | https://www.veeva.com/media/rims-new-ceo-is-staying-the-course/ | 2012-01-27|http://www.businessweek.com/magazine/rims-new-ceo-is-staying-the-course-01262012.html | | In this article, Bloomberg Businessweek turns the spotlight on how Apple’s iPad has dominated the first major new corporate hardware market in years. Veeva’s Matt Wallach comments on the rapid uptake of the iPad among 95% of Veeva customers, and how “The iPad’s success in the enterprise means that RIM is dead, at least in pharma.”| Veeva CRM Now Integrated with Concur and Group DCA | https://www.veeva.com/media/veeva-integrates-crm-system-with-concur-and-group-dca/ | 2012-01-05|http://www.destinationcrm.com/Articles/CRM-News/Daily-News/Veeva-Integrates-CRM-System-with-Concur-79725.aspx | | Integration is the key word in this article highlighting Veeva’s recent announcements on our seamless interactions with Concur for expense management and Group DCA for Digital Detailing.| Leading Pharma Company Employs Veeva CRM for Enterprise-Wide Deployment | https://www.veeva.com/media/leading-pharma-company-employs-veeva-crm-for-enterprise-wide-deployment/ | 2011-12-01|http://outbound-call-center.tmcnet.com/topics/outbound-call-center/articles/73244-leading-pharmaceutical-company-employs-veeva-crm-enterprise-wide.htm | | Seeking a single solution that would connect their entire US sales organization, this newly merged top 10 pharma company selects Veeva CRM citing Veeva’s multitenant SaaS architecture, flexibility, low cost and easy integration as key differentiators. Veeva CRM provides the perfect fit functionally and the most cost effective solution.| Cut the Cord & Take to the Cloud | https://www.veeva.com/media/cut-the-cord-take-to-the-cloud/ | 2011-12-01|/wp-content/uploads/2011/12/rep21691067_pe_ePrint_LR.pdf | | While cloud computing might be the catchphrase of the moment, not all systems are created equal. A feature that should be considered when looking for a new software-as-a-service (SaaS) system is multitenancy which is a chief characteristic of a mature cloud computing application. Matt Wallach discusses this important distinction in this article.| Software as a Service Gaining Traction | https://www.veeva.com/media/software-as-a-service-gaining-traction/ | 2011-12-01|/wp-content/uploads/2011/12/PharmaVOICE0410_SaaS.pdf | | As industries around the world increase SaaS use, pharmaceutical companies are following suit. Experts discuss the growing use of SaaS in the industry and offer predictions for future applications.| True SaaS Transforms Sales Automation Systems to Make Upgrades Painless | https://www.veeva.com/media/true-saas-transforms-sales-automation-systems-to-make-upgrades-painless/ | 2011-12-01|http://www.pharmaceuticalcommerce.com/frontEnd/1427-Veeva_CRM_SFA_SaaS_Wallach_pharma.html | | Multitenant sales force automation (SFA) systems are coping with an increasingly complex regulatory environment necessitating flexible and cost effective solutions. Only a true multitenant SaaS solution can cost-effectively support the constantly shifting, complex regulatory environment facing today’s life sciences companies.| Veeva Systems Launches Industry’s First SaaS CRM Application Network | https://www.veeva.com/media/veeva-systems-launches-industrys-first-saas-crm-application-network/ | 2011-12-01|http://outbound-call-center.tmcnet.com/topics/hosted-call-center/articles/84987-veeva-systems-launches-simple-cost-effective-life-science.htm | | Extending the use and reach of Veeva CRM, Veeva Web removes the cost and complexity of system integration. Veeva Web is a prime example of the business value that a mature multitenant architecture can deliver, going beyond the “connector” approach to system integration delivering truly joint solutions that span multiple product areas.| Weathering the Compliance Storm | https://www.veeva.com/media/weathering-the-compliance-storm/ | 2011-12-01|http://pharmexec.findpharma.com/pharmexec/article/articleDetail.jsp?id=670570&sk=&date=&&pageID=1 | | Compliance concerns mount in the midst of constantly changing regulations. The majority of CRM systems are simply not built to weather this kind of change. Only SaaS CRM applications based on the cloud-computing model are uniquely designed to be able to change as frequently as regulations change providing pharma the necessary umbrella to weather any compliance storm.| Tickets.com, Others Follow Google, Amazon Lead in Opening Up | https://www.veeva.com/media/tickets-com-others-follow-google-amazon-lead-in-opening-up/ | 2011-12-01|http://www.pcworld.com/businesscenter/article/203208/ticketscom_others_follow_google_amazon_lead_in_opening_up.html | | More and more cloud computing companies are opening their doors to outside developers and are reaping the benefits, not only in revenue but also in watching their platform grow in ways they never imagined.| Veeva, Salesforce.com Tighten Pairing to Target Pharma, Biotech | https://www.veeva.com/media/veeva-salesforce-com-tighten-pairing-to-target-pharma-biotech/ | 2011-12-01|http://www.crn.com/news/cloud/227900057/veeva-salesforce-com-tighten-pairing-to-target-pharma-biotech.htm;jsessionid=SDrB9A34xrTmsWl45vRasg**.ecappj03 | | Find out why Veeva’s enhanced partnership with salesforce.com can help bring more pharmaceutical companies into the cloud.| CRM in the Cloud | https://www.veeva.com/media/crm-in-the-cloud/ | 2011-12-01|http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20101124/#/8/OnePage | | Dan Goldsmith of Veeva Europe explains why multitenant SaaS technology — or cloud technology — is becoming the glue that enables life science businesses to remain close to patients, prescribers and payers and to do so more cost-effectively than ever before.| Reps of Tomorrow Will Need Both Sciences & CRM Skills | https://www.veeva.com/media/reps-of-tomorrow-will-need-both-sciences-crm-skills/ | 2011-12-01|http://viewer.zmags.com/publication/d5bfcc6f#/d5bfcc6f/102 | | Future sales models will require reps to vary their roles beyond the current basic product knowledge and promotional messaging. Veeva’s Dan Goldsmith and Matt Wallach weigh in on the topic.| iRep Lets Docs Sign an iPad for Samples | https://www.veeva.com/media/irep-lets-docs-sign-an-ipad-for-samples/ | 2011-12-01|http://www.mmm-online.com/irep-lets-docs-sign-an-ipad-for-samples/article/194504/ | | iRep continues to get great press. This article talks about why the product is so innovative and how the industry is responding to the launch.| Veeva Systems Unveils Content Management Solution for Life Sciences | https://www.veeva.com/media/veeva-systems-unveils-content-management-solution-for-life-sciences/ | 2011-12-01|http://itsoftware.pharmaceutical-business-review.com/news/veeva-systems-unveils-content-management-solution-for-life-sciences-160211 | | Pharmaceutical Business Review writes about Veeva’s ground-breaking new product, Veeva Vault.| Cloud-Based IT Offering Manages Control of Marketing & Education Documents | https://www.veeva.com/media/cloud-based-it-offering-manages-control-of-marketing-education-documents/ | 2011-12-01|http://www.pharmaceuticalcommerce.com/frontEnd/main.php?idSeccion=1605 | | Pharmaceutical Commerce interviewed Veeva Vice President, Jennifer Goldsmith on Veeva Vault, our latest cloud offering for the life sciences industry.| A Decade of Change | https://www.veeva.com/media/a-decade-of-change/ | 2011-12-01|http://viewer.zmags.com/publication/01bf29e7#/01bf29e7/34 | | All in all, the decade can be defined as one of tremendous change – and it’s not expected to end any time soon. In the March issue of PharmaVOICE, Veeva Systems’ Chief Strategy Officer, Matt Wallach, along with industry experts review the top 10 game changes of the past decade and set the stage for what pharma can expect heading into the next decade. Business as usual is only true if one defines “usual” as “change”.| Veeva Launches First iPad CRM/CLM Cloud Application | https://www.veeva.com/media/veeva-launches-first-ipad-crmclm-cloud-application/ | 2011-12-01|http://call-center-software.tmcnet.com/topics/call-center-software/articles/167966-veeva-launches-first-ipad-crmclm-cloud-application.htm | | Apple’s recent upgrades to the ever popular iPad seem to create endless possibilities for life sciences companies using Veeva Systems’ new iRep. iRep, the first CRM+CLM application for life sciences designed specifically for the iPad, is yet another innovative product from Veeva which recently expanded its partnership with salesforce.com to accelerate the delivery of Veeva CRM applications to the global pharmaceutical and biotechnology industry.| What the Cloud Can Do for You | https://www.veeva.com/media/what-the-cloud-can-do-for-you/ | 2011-12-01|/wp-content/uploads/2011/12/What_the_cloud_can_do_for_you_PharmRep0411.pdf | | Type “cloud” into Google and you’ll get some 480 million hits, but what can it really do for sales reps? The April 2011 issue of Pharmaceutical Representative features a story by Veeva founder Matt Wallach that outlines 10 ways that the cloud can help pharma reps do their jobs even better.| Industry Experts Challenge the Status Quo on Content Management | https://www.veeva.com/media/industry-experts-challenge-the-status-quo-on-content-management/ | 2011-12-01|/wp-content/uploads/2011/12/thefutureofregulatedcontentmanagement.pdf | | As seen in PharmaVOICE magazine, Veeva gathers five life sciences industry experts from top pharmaceutical and consulting companies to debate the past and future of regulated content management systems. Read as these industry experts discuss the need for companies’ business technologies to catch up to their rapidly changing industry.| Effective CRM in China: A Large & Moving Target | https://www.veeva.com/media/effective-crm-in-china-a-large-moving-target/ | 2011-12-01|/wp-content/uploads/2011/12/MedAdNews-Effective-CRM-in-China.pdf | | As multinational pharmaceutical companies execute their strategies for growth in China, they are well advised to take a fresh and different approach to customer relationship management, advises Cindy Zhang of Veeva China.| Veeva to Hire 50 as Drug, Device Companies Head to the Cloud | https://www.veeva.com/media/veeva-to-hire-50-as-drug-device-companies-head-to-the-cloud/ | 2011-12-01|http://www.bizjournals.com/sanfrancisco/blog/biotech/2011/08/veeva-salesforce-crm-cloud-computing.html | | Veeva Systems is taking drug companies into the cloud and facing down big-name players like Oracle Corp.| Veeva, ZS Associates Partner to Combine SFA Services | https://www.veeva.com/media/veeva-zs-associates-partner-to-combine-sfa-services/ | 2011-12-01|http://www.pharmaceuticalcommerce.com/frontEnd/1723-Veeva_ZS_Publicis_SFA_Keefer.html | | Veeva Systems and ZS Associates partner together to provide life sciences companies with an automated, end-to-end solution that greatly streamlines sales processes.| Relationship Building | https://www.veeva.com/media/relationship-building/ | 2011-12-01|http://viewer.zmags.com/publication/7e0af12c#/7e0af12c/102 | | Paul Shawah, VP, Multichannel Strategy, comments on how sales reps can make face-to-face interactions with physicians as meaningful as possible.| Building a Culture of Innovation | https://www.veeva.com/media/building-a-culture-of-innovation/ | 2011-11-27|http://viewer.zmags.com/publication/7e0af12c#/7e0af12c/36 | | Jen Goldsmith, VP, Veeva Vault, comments in this article on pharmaceutical R&D. Under pressure to counter rising costs, depleted pipelines and impending patent expiries, the industry is facing not only a productivity crisis but also a crisis in innovation.|
New advisory capability for field reps will be built into Veeva’s CRM
At Veeva’s Commercial Excellence Summit (Philadelphia; June 10-11), Veeva Systems gave its clients reviews and previews of new IT capabilities being built into its offerings, which now range from customer relationship management (CRM) for sales reps to enterprise-level document-management, master-data management and networking tools for pharma organizations. The most eyecatching announcement, though, is Veeva CRM Suggestions, a capability being built into CRM to synthesize diverse multichannel-communications data (for example, email communications and call-center activity) with customer demographic and business data. The CRM would then offer “suggestions” to the rep as to next activity when calling on a physician or healthcare manager. These messages would be delivered rapidly to reps in the field so that they can act on them in a timely manner.
|At Veeva’s Commercial Excellence Summit (Philadelphia; June 10-11), Veeva Systems gave its clients reviews and previews of new IT capabilities being built into its offerings, which now range from customer relationship management (CRM) for sales reps to enterprise-level document-management, master-data management and networking tools for pharma organizations. The most eyecatching announcement, though, is Veeva CRM Suggestions, a capability being built into CRM to synthesize diverse multichannel-communications data (for example, email communications and call-center activity) with customer demographic and business data. The CRM would then offer “suggestions” to the rep as to next activity when calling on a physician or healthcare manager. These messages would be delivered rapidly to reps in the field so that they can act on them in a timely manner. At Veeva, Innovation Comes From Careful Planning | https://www.veeva.com/media/at-veeva-innovation-comes-from-careful-planning/ | 2015-05-29|http://news.investors.com/management-managing-for-success/052915-754866-peter-gassner-veeva-systems-focuses-on-select-few-priorities.htm | | When Peter Gassner worked in construction during high school, he learned an important lesson: Measure twice, cut once. He follows that rule in building a business. He makes decisions through information gathering and careful planning.| Capturing the Cloud: A Conversation with Veeva Systems Matt Wallach | https://www.veeva.com/media/capturing-the-cloud-a-conversation-with-veeva-systems-matt-wallach/ | 2015-05-29|http://www.pharmexec.com/capturing-cloud-conversation-veeva-systems-matt-wallach | | In another of our conversations with leading CEO innovators transforming the pharma business model, Pharm Exec sits down with Matt Wallach, co-founder and President of Veeva Systems, an upstart start-up whose mix of cutting-edge technology and a strong customer orientation has brought it to the top rank in providing cloud-based data management services to the life science industry. So inherently conservative are companies in this industry that the advantages of cloud-based data solutions are only now being recognized – but the pace of innovation is more than making up for lost time.| Eli Lilly’s Field Reps: Armed With Data | https://www.veeva.com/media/eli-lillys-field-reps-armed-with-data/ | 2015-04-02|http://www.informationweek.com/strategic-cio/executive-insights-and-innovation/eli-lillys-field-reps-armed-with-data-/d/d-id/1141542 | | Cloud-based, mobile-friendly system gives sales force greater insight into the drugmaker’s customers. One of eight profiles of InformationWeek Elite 100 Business Innovation Award winners.| The 25 Most Valuable Cloud Computing Companies Are worth Way More Than You’d think | https://www.veeva.com/media/the-25-most-valuable-cloud-computing-companies-are-worth-way-more-than-youd-think/ | 2015-01-28|http://www.businessinsider.com/25-most-valuable-cloud-companies-2015-1?op=1 | | With Box’s successful IPO last week, there are now 25 public companies in the cloud computing market worth more than $1 billion, according to Bessemer Venture Partners’ Cloud Index. And the market cap of the top 30 cloud tracked by the BVP Cloud index hit more than $155 billion last week, too. (The index tracks 41 public companies.)| Pharma Company Prefers Vertical Industry Cloud | https://www.veeva.com/media/pharma-company-prefers-vertical-industry-cloud/ | 2014-11-25|http://www.cio.com/article/2847467/cloud-computing/pharma-company-prefers-vertical-industry-cloud.html | | Cloud services designed specifically for particular industries are becoming more common, especially in highly regulated fields. That benefits companies such as Questcor Pharmaceuticals, which wanted a cloud-based CRM system but couldn’t find what it needed from one-size-fits-all vendors.| CRO-sponsor Partnerships Require Planning, Time to Develop | https://www.veeva.com/media/cro-sponsor-partnerships-require-planning-time-to-develop/ | 2014-11-14|/wp-content/uploads/2014/11/BioWorld_Veeva.pdf | |A report from Tufts Center for the Study of Drug Development (CSDD) highlights the evolving relationships between contract research organizations (CROs) and clinical trial sponsors through the adoption of strategic partnerships. In 2008, Eli Lilly and Co., of Indianapolis, sold one of its research facilities to Covance Inc. and signed a 10-year service agreement for everything from drug discovery through phase III development with the Princeton, N.J.-based CRO.
In 2011, New York-based Pfizer Inc. signed deals with both Dublin-based Icon plc and Parexel International Corp., of Waltham, Mass. The five-year deals weren’t designed to increase Pfizer’s outsourcing activities but to consolidate the number of external service providers the pharma used for clinical trial execution.
| Master Data Management Takes Center Stage | https://www.veeva.com/media/master-data-management-takes-center-stage/ | 2014-11-13|http://www.pharmaceuticalcommerce.com/index.php?pg=information_technology&articleid=27318&keyword=compliance.%20concerns-master%20data-Sunshine%20Act | | There’s no question that the Physicians Sunshine Act—that part of Obamacare that mandates the reporting of payments and contributions of “transfers of value” to healthcare providers (HCPs) by the life sciences industry—has had a major impact on the business of providing HCP identifications, locations and affiliations. These “master data files” have been a steady business for years for the American Medical Assn. (which sells its data to a group of database licensees) and a host of private companies. The Sunshine Act mandates public disclosure of industry payments, aggregated by HCP over the course of a year; at presstime, the first national, industry-wide disclosure was to occur around Sept. 30—but if AMA and others have their way, could be delayed to March 2015| Trial Documents: Only 13% of Firms are Fully Paperless | https://www.veeva.com/media/trial-documents-only-13-of-firms-are-fully-paperless/ | 2014-11-13|http://www.outsourcing-pharma.com/Clinical-Development/Trial-documents-only-13-of-firms-are-fully-paperless-says-Veeva | | Contract research organisations (CROs) have been slow to adopt next-generation means of recording study documents, with only 13% using the most up-to-date technologies, according to cloud-based services company Veeva.| Veeva Vault eTMF Selected by Princeton-based inVentiv Health Clinical for Clinical Trial Master Files | https://www.veeva.com/media/veeva-vault-etmf-selected-by-princeton-based-inventiv-health-clinical-for-clinical-trial-master-files/ | 2014-11-10|http://www.phillytechnews.net/2014_11_07_archive.html | | inVentiv Health Clinical, a leading global supplier of drug development services, announced last month it will replace its electronic trial master file (eTMF) with Veeva Vault eTMF. Cloud-based, multitenant Vault eTMF, Veeva says, “delivers secure, instant access to inspection-ready documentation and enables seamless collaboration between inVentiv, trial sponsors, and trial sites worldwide – ultimately helping to speed time to submission and product approval.”| Veeva Systems Flies High On Cloud For Life Sciences | https://www.veeva.com/media/veeva-systems-flies-high-on-cloud-for-life-sciences/ | 2014-10-30|http://news.investors.com/103014-724274-software-maker-veeva-growing-fast-on-cloud-products.htm?ven=yahoocp&src=aurlled&ven=yahoo | | Before founding software company Veeva Systems in 2007, Peter Gassner was certain of two things. He wanted the technology to be cloud-based and to address critical issues for a specific industry. He decided to focus on life sciences. “We could have picked something else, like oil and gas. But that’s the one we picked. For one thing, it’s a big industry and I like big industries. I knew there was a massive need for good cloud solutions,” he told IBD. Turned out to be a good idea —Veeva (NYSE:VEEV) is one of the most successful cloud-based software companies around. Not only has revenue been growing in double digits, it’s also profitable.| Cloud Marketing: Cloud Power | https://www.veeva.com/media/cloud-marketing-cloud-power/ | 2014-10-29|http://www.mmm-online.com/cloud-marketing-cloud-power/article/378711/ | | MM&M – In a perfect world, everything a life-sciences marketing exec could ever need would be stashed in the cloud. He could upload relevant consumer feedback as effortlessly as if he were transferring family photos to Dropbox. And he—not to mention the sales teams with which he regularly liaises, R&D staffers and the FDA—could access real-time clinical-trial updates at the same moment. While cloud computing for healthcare organizations hasn’t achieved the simplicity or power of many consumer-facing applications, it’s getting closer, in part due to the rising expectations of app-happy marketing execs. “The same people that love to shop on Amazon go to work in this industry, and they are expecting the same ease of use,” says Paul Shawah, VP/CRM strategy for cloud-based software provider Veeva Systems.| What these 6 CEOs learned from working at Salesforce | https://www.veeva.com/media/what-these-6-ceos-learned-from-working-at-salesforce/ | 2014-09-02|http://www.citeworld.com/article/2600330/sales-marketing-tech/salesforce-mafia-interviews.html | |Citeworld – Salesforce launched 15 years ago. With annual revenues expected at more than $5 billion this year, it is hard to remember those days when Salesforce was a scrappy start up, trying to sell enterprise customers on the benefits of the multi-tenant software-as-a-service model. That battle is long over, and since then Salesforce has gone on to introduce a number of other new innovations that were also promptly snapped up with the rest of the industry. Chatter comes to mind; so does its latest product, Community Cloud.
Less has been said, though, about the generation of new tech executives cultivated by Salesforce. In many ways the company has become a de facto training ground in this industry — much like Oracle was in the 1990s.
Salesforce CEO Marc Benioff, of course, is an Oracle alum so it shouldn’t be surprising that he is repeating history. But while the careers of Salesforce’s executive progeny are interesting to follow, what is truly telling is what they have gone on to do since their stints at the company.
We talked to several of them. Here’s what they told us.
| Veeva: Moving the Life Sciences Industry to the Cloud | https://www.veeva.com/media/veeva-moving-the-life-sciences-industry-to-the-cloud/ | 2014-09-02|http://www.bloomberg.com/news/videos/b/3dbc4097-d8fb-4772-b22d-1733233e5df4 | | Aug. 29 (Bloomberg) — Peter Gassner, founder and CEO of Veeva Systems, discusses the demand for cloud-based software with Cory Johnson on “Bloomberg West.” (Source: Bloomberg) |Aug. 29 (Bloomberg) — Peter Gassner, founder and CEO of Veeva Systems, discusses the demand for cloud-based software with Cory Johnson on “Bloomberg West.” (Source: Bloomberg) Check out these playbooks from successful industry cloud startups | https://www.veeva.com/media/check-out-these-playbooks-from-successful-industry-cloud-startups/ | 2014-05-06|http://venturebeat.com/2015/01/30/check-out-these-playbooks-from-successful-industry-cloud-startups/ | | Industry cloud software companies are on the verge of taking off, with several already achieving multibillion-dollar valuations. At Bessemer, we’ve been fortunate to partner with more than a dozen industry software companies. And we’ve watched them attack the field in a variety of ways.| Cerner, Athenahealth and Veeva Chase Cloud-Based EHR | https://www.veeva.com/media/cerner-athenahealth-and-veeva-chase-cloud-based-ehr/ | 2014-05-06|http://www.nasdaq.com/article/cerner-athenahealth-and-veeva-chase-cloud-based-ehr-cm436129 | | A new wrinkle in federal rules this year aims to urge more hospitals and other medical providers into the 21st century. Those expectations have helped lift a handful of companies in IBD’s Computer Software-Medical group, a group at the intersection of health care and Internet technology — and key suppliers to the health industry’s conversion from paper to digital electronic records.Cerner (CERN),Athenahealth (ATHN) andVeeva Systems (VEEV) are at the head of that list. All three have seen benefits from the American Recovery and Reinvestment Act of 2009, also known as the stimulus bill. All have also seen their share of recent ups and downs.| The Cloud’s Long Tail: Industry-Specific SaaS Solutions | https://www.veeva.com/media/the-clouds-long-tail-industry-specific-saas-solutions/ | 2014-04-16|http://www.ecommercetimes.com/story/80281.html | | I’ve been suggesting for a number of years that a new wave of opportunities is emerging to create industry-specific Software as a Service and cloud computing vertical market solutions. A number of new examples of this phenomenon have crossed my radar over the past few weeks which clearly illustrate the long tail effect of the cloud. The most prominent example of the verticalization of the SaaS marketplace over the past year has been the successful IPO of Veeva and the success of the company overall.| Eli Lilly’s Sales Force Finds CRM Harmony in the Cloud | https://www.veeva.com/media/eli-lillys-sales-force-finds-crm-harmony-in-the-cloud/ | 2014-04-02|http://www.fiercepharmamarketing.com/story/eli-lillys-sales-force-finds-crm-harmony-cloud/2014-04-02?utm_medium=nl&utm_source=internal | | Moving pharma’s IT into the cloud could save a lot of money, the IMS Institute for Healthcare Informatics told us a few weeks ago. Eli Lilly ($LLY) may not yet know that firsthand. But its reps do know that cloud-based systems save them a lot of aggravation. That’s the word from InformationWeek, which handed Lilly an innovation award for its sales force-systems revamp. Before, reps presented sales promos on bulky Windows-based tablets that took ages to boot up while doctors stood by, waiting. After, they use a Veeva Systems ($VEEV) app on their iPads, not only for presentations, but to plan sales calls, report their results back to the office, and analyze trends, the magazine reports.| NYSE Big StartUp: Veeva | https://www.veeva.com/media/nyse-big-startup-veeva/ | 2014-04-01| | | Peter Gassner, CEO of Veeva, talks with with Guy Kawasaki about building a company that brings cloud solutions to the life sciences industry. |Peter Gassner, CEO of Veeva, talks with with Guy Kawasaki about building a company that brings cloud solutions to the life sciences industry. Veeva Expands Physician-contact Tools with Engage, a Multichannel Communications Link | https://www.veeva.com/media/veeva-expands-physician-contact-tools-with-engage/ | 2014-03-21|http://pharmaceuticalcommerce.com/latest_news?articleid=27168 | | Veeva (Pleasanton, CA) started as a conventional (if cloud-based) salesforce-automation (SFA) tool, but in the past couple years has expanded its capabilities to include storage and sharing of promotional documents, laboratory filings, master-data management and regulated email. Now it is adding multichannel communications—with an emphasis on mobile—to its slate of offerings. The new service, called Engage, enables pharma sales reps to communicate with physicians via interactive voice or email.|Veeva (Pleasanton, CA) started as a conventional (if cloud-based) salesforce-automation (SFA) tool, but in the past couple years has expanded its capabilities to include storage and sharing of promotional documents, laboratory filings, master-data management and regulated email. Now it is adding multichannel communications—with an emphasis on mobile—to its slate of offerings. 12 Internet Players You’ll Want to Know About | https://www.veeva.com/media/12-internet-players-youll-want-to-know-about/ | 2014-03-19|https://www.yalealumnimagazine.com/articles/3842?page=2 | | Matt Wallach ’94 views one of his jobs as helping to get the right medications to the right people. As cofounder and president of Veeva Systems, he develops cloud-based software for life sciences companies like Pfizer. That includes e-mail, customer portals, and technology that helps pharmaceuticals sales representatives to manage their interactions with physicians. “This industry gets kind of a bad rap,” Wallach concedes. But, he says, the sales reps have to educate doctors on which new drugs are available and how they should be used. And he wants to help them do that more effectively.|Matt Wallach ’94 views one of his jobs as helping to get the right medications to the right people. As cofounder and president of Veeva Systems, he develops cloud-based software for life sciences companies like Pfizer. Veeva CEO Featured on CNBC’s “Executive Decision” | https://www.veeva.com/media/veeva-ceo-featured-on-cnbcs-executive-decision/ | 2014-03-10| | | For his second “Executive Decision” segment, Cramer spoke with Peter Gassner, co-founder and CEO of Veeva Systems (VEEV). Gassner explained that Veeva brings cloud-based applications to life science companies, helping to take a $1.6 trillion industry away from inefficient client-server-based software and into an easier-to-use and more cost-effective way of doing business. | New Cloud-Software Firms Take Off | https://www.veeva.com/media/new-cloud-software-firms-take-off/ | 2014-03-04| | |Spencer E. Ante
Wall Street Journal – March 4, 2014Salesforce.com Inc. CRM +2.40% pioneered the cloud-software business and is valued at almost $40 billion. Now a second wave of more specialized online software companies is starting to take off and command rich multibillion-dollar valuations that may be hard to sustain. The companies have unfamiliar names like Veeva Systems Inc., VEEV -0.79% Cvent Inc., CVT -1.34% and DocuSign Inc., and are tackling specific industries such as health care and hospitality or slices of the market such as marketing and project management. “The market is large enough that you can sell into one vertical,” said Bryan Schreier, a partner at Sequoia Capital, which has financed cloud software companies Dropbox Inc. and RingCentral Inc., RNG +2.04% among others. “These companies have a long way to grow.” The rise of niche providers could crimp the growth of big software makers such as Oracle Corp. ORCL +2.05% , SAP AG SAP.XE +0.37% , Salesforce.com and International Business Machines Corp. IBM +0.62% , while presenting a larger threat to company-built software or programs from lower-tier players that have been slow to shift to the Internet. “We believe there is a great white-space opportunity in delivering apps and infrastructure to specific industries and verticals,” wrote Wells Fargo Securities analyst Jason Maynard in a recent report naming “industry clouds” as one of the top 10 software trends of the year. Unlike Salesforce.com and Workday Inc., WDAY +4.02% which offer one-size-fits-all software, some of the specialized providers are profitable and have better margins since they don’t have to spend as much on sales and marketing. But some customers warn of potential problems with future growth, saying smaller companies providing industry-specific software could have trouble meeting the needs of global clients. Historically, investors shied away from financing niche players because they thought the markets were too small. But in recent years these companies have taken off as the technology has become easier to use and cheaper, broadband Internet service has become pervasive, and customers are more open to using cloud software. Their business models are also attractive to investors, requiring customers to pay a low but recurring monthly fee. Last year, a dozen cloud software companies such as pharmaceutical software maker Veeva Systems and event-planning software maker Cvent held public offerings, posting an average return of about 50%, according to IPO investment adviser Renaissance Capital. These companies are trading at ultra-high valuations. Veeva Systems, which is valued at more than $4 billion, trades at about 158 times expected earnings for 2015, while Cvent and its near-$2 billion market value trades at nearly 400 times expected earnings. Salesforce, meanwhile, has a multiple of around 90 times expected earnings. Several more cloud software companies are in the IPO pipeline, including payroll processor Paylocity Corp., banking-services provider Q2 Holdings Inc. and global trading software maker Amber Road Inc. Another startup, electronic signature software company DocuSign, said Tuesday it raised $85 million in a deal that values the company at about $1.6 billion, a person familiar with the matter said. Some of the companies are turning a profit, unlike the heavy losses from Salesforce.com and Workday, which spend roughly 40% to 50% of their revenue on sales and marketing to grab customers. The specialized cloud companies are able to spend less on marketing because it can be more targeted, and word-of-mouth recommendations travel faster in single industries, say executives. RealPage Inc. a maker of cloud software to help manage rental properties, earned $21 million on $377 in revenue in 2013. Sales and marketing consumed about 25% of its sales. Veeva, which sells marketing software for pharmaceutical and biotechnology companies, posted a $24 million profit on $210 million in sales in the fiscal year ended Jan. 31, according to its earnings report released Tuesday. Sales and marketing expenses accounted for only 20% of Veeva’s revenue. Seven-year-old Veeva is winning over big customers such as drug maker Mylan Inc., MYL +0.29% which last fall began a global rollout of some Veeva applications. The software will help thousands of Mylan salespeople to manage relations with their customers in a highly regulated industry, replacing manual processes, custom-built and packaged programs used all over the company with one system accessible over the Web. Michael Smith, chief information officer of Mylan, said the company chose Veeva over programs from Oracle, SAP, Salesforce.com, and Microsoft Corp., older companies that make software for a range of industries and business tasks. He said it would take 18 to 24 months to introduce Veeva around the world, compared to four to six years for packaged software run on its own computers. Since Veeva concentrates on life sciences, it has been able to build numerous unique features, such as giving salespeople the ability to quickly look up the drug reimbursement policies of dozens of insurers, or displaying which states prohibit nurses from receiving drug samples. “We are very close to our customers,” said Veeva Systems CEO Peter Gassner. Marty Hoski, global manager of travel and meeting operations for SAT provider Educational Testing Service, is a big fan of Cvent’s software. He chose it over programs from Oracle and SignUp4, another specialized provider. Mr. Hoski said SignUp4 was “limited in what it could do” and “time, scope and cost was through the roof to get an Oracle module in place that would have had very limited functionality.” SignUp4 and Oracle declined to comment. A couple of years ago, Mr. Hoski had little control over the $40 million the company spent annually on meetings. Administrative assistants would sign pricey contracts for venues. Invites went out with typos and bad grammar. “We had no idea what they were doing,” he said. Now, using Cvent, Mr. Hoski’s meeting planners can bid out a deal to its network of suppliers, execute the contract, and manage the marketing of the event all from a Web browser. The additional oversight and leverage provided by Cvent software saves the company about $8 million a year, he said, while improving the quality of the events.
|Salesforce.com Inc. pioneered the cloud-software business and is valued at almost $40 billion. Now a second wave of more specialized online software companies is starting to take off and command rich multibillion-dollar valuations that may be hard to sustain.
Digital Think Tank: A Work in Progress | https://www.veeva.com/media/digital-think-tank/ | 2014-02-28|http://www.mmm-online.com/digital-think-tank-a-work-in-progress/article/334775/ | | Paul Shawah, Veeva’s vice president of commercial strategy, offers elevator insights on the state of digital pharma–the ups, the downs and how to get to the next level. What has encouraged you most in the past 12 months in digital pharma? In what areas is progress being made? In a word… “speed.” Pharma is generally perceived as slow-moving, but digital capabilities are rapidly emerging—and the industry’s willingness to adopt these tools is growing. Companies are motivated to leverage digital innovations that enhance customer engagement. One example is personalized communications with HCPs using tools like email. Long considered taboo, email is an exciting capability companies are embracing thanks to solutions that remove the compliance risk. And what continues to frustrate you? Where are the major challenges and roadblocks, and what needs to be done to overcome them? Even with the industry’s newfound willingness to test digital capabilities, learn and scale, there remain organizational barriers every step of the way. The “innovator’s dilemma” is alive and well—it’s hard to change processes and selling models that proved successful in the not-so-distant past. To fully go “digital” and successfully navigate through the increased pace of business that digital makes possible, organizational structure, processes and commercial models must be reinvented. What will be the most important digital pharma trend(s) in the next 12 months? By far, the most important trend in digital for the life sciences industry will not be a new technology, but rather…a new mindset—a commitment to making digital communications an integrated part of the promotional mix. Optimal results only occur when digital is strategically combined and aligned with the activities of the field force. Next year, the industry will look for ways to identify and orchestrate the best promotional mix—digital, face-to-face, email—for each customer.|Paul Shawah, Veeva’s vice president of commercial strategy, offers elevator insights on the state of digital pharma–the ups, the downs and how to get to the next level. What has encouraged you most in the past 12 months in digital pharma? In what areas is progress being made? In a word… “speed.” Pharma is generally perceived as slow-moving, but digital capabilities are rapidly emerging—and the industry’s willingness to adopt these tools is growing.
The Top 10 Customer Relationship Management Services | https://www.veeva.com/media/the-top-10-customer-relationship-management-services/ | 2014-02-21|http://venturebeat.com/2014/02/11/top-10-crm-services/ | | Businesses grow when they maintain healthy relationships with their customers. For your local deli, that might mean a quick chat to go with your pastrami sandwich. But for companies with more complex operations, customer relationship management (CRM) software is often essential. Every CRM solution comes in a different flavor — and at a different price. There’s CRM software that enables employees to create, assign, and manage requests made by customers — so when you call your cable company, for example, a representative can pull up your file to view your prior service history and log new information. CRM sales software provides companies with a suite of tools to manage the entire sales process, from initial lead qualification to opportunity management, forecasting, and eventually deal closure. CRM marketing systems can track campaigns over various channels, such as traditional mail and phone efforts, email, search, and social media.|
2013 IPO Scorecard: Here are the 27 Winners, Losers of Silicon Valley, Bay Area | https://www.veeva.com/media/2013-ipo-scorecard-here-are-the-27-winners-losers-of-silicon-valley-bay-area/ | 2014-02-20|http://www.bizjournals.com/sanjose/news/2013/12/13/2013-ipo-winners-losers-in-silicon.html?s=image_gallery | | Up 65%: Veeva Systems, led by CEO Peter Gassner, raised $261 million in an October IPO that debuted on the NYSE with a more than 80 percent jump in price. The IPO price was $20 and it closed on Dec. 19 at $32.94. The Pleasanton-based life-sciences software company’s biggest backer is Emergence Capital Partners.|
The True Power of Cloud Software | https://www.veeva.com/media/the-true-power-of-cloud-software/ | 2014-02-14|http://www.cioreview.com/magazine/The-True-Power-of-Cloud-Software-UCIB929108054.html | | Organizations are rapidly moving from pre-internet client-server software to more flexible cloud-based solutions. The basic advantages of cloud-based software are well known. Companies can deploy the software in a matter of weeks or months rather than years. They can pay as they go and get the latest updates quickly and continuously. And cloud software enables companies to respond and adapt to business issues that arise unexpectedly.|
Can Veeva Systems’ Software Keep Luring Big Pharma? | https://www.veeva.com/media/can-veeva-systems-software-keep-luring-big-pharma/ | 2014-01-06|http://news.investors.com/business-the-new-america/021715-739578-veeva-is-primed-to-keep-up-share-gains-in-life-science-crm.htm?ref=HPLNews | | It takes some doing for a small fry to make a dent in a market ruled by industry big shots. But that’s what software service provider Veeva Systems (VEEV) has done since making its market debut in October 2013, as it’s taken share from larger rivals that were using older technology. Veeva, founded in 2007, specializes in providing cloud-based software to the life sciences industry.|
Stop Pouting About Tech’s Next Big Thing, It’s Here | https://www.veeva.com/media/stop-pouting-about-techs-next-big-thing-its-here/ | 2014-01-03| | | 2013 Was Not a Lost Year. Plus, Three Tech Trends to Watch in 2014 Wall Street Journal – December 31, 2013It’s easy to get jaded when you cover the technology industry. Silicon Valley’s giants are constantly belching wisps of marshmallow-thick hype, and any reporter looking to cover the beat has to be constantly on guard against unproven claims about this or that algorithmically-abetted amazing advance. And another thing: We’re witnessing the dawn of a new paradigm in machine-human cooperation Everett Collection So when Christopher Mims of Quartz recently declared 2013 to be a “lost year for tech”—one in which, he says, the industry produced nothing of great value—I could see where he was coming from. I feel the same way some days; when I’m covering some new me-too social-media product or a great new way to target ads, I hang my head in despair. But then I read a couple of rebuttals to Mims by Daring Fireball’s John Gruber and Om Malik, of Gigaom. They argued that the industry’s biggest advances have occurred beneath the media’s radar, and that the industry, as a whole, is anything but stagnant. I side with these more positive takes. Here’s my roundup of reasons to break out of your tech funk and be optimistic about tech in 2014. First, stop clamoring for the “next big thing.” Were you disappointed, once again, that Apple AAPL +0.39% didn’t release something amazing and new this year—a TV or a smartwatch, say? Were you bummed that there were few revolutionary features on the latest smartphones? Have you concluded that the tech business is boring, that there isn’t any more innovation, that we live in uninteresting times? I, too, constantly yearn for mind-blowing new tech. But I’ve been getting tired of the claim that just because we haven’t seen something on the order of the smartphone or tablet in the last few years, the tech industry can no longer innovate. The problem with this argument is that the touchscreen smartphone (and its cousin the tablet) was a singularly novel, industry-shattering device, and we’re unlikely to see anything as groundbreaking in a generation. The smartphone and the tablet *are* the next big things, and we act like spoiled children when we claim that they somehow aren’t enough. Most future advances will simply be improvements or expansions on these basic technologies—ways to make smartphones and tablets cheaper, more powerful, smaller, lighter, and to let them control and connect with an ever-larger slice of our lives. In 2013 we saw several such innovations. Google’s GOOG +1.66% Motorola MSI +0.22% subsidiary released a really good phone, the Moto G, that sells for $199 without a contract—the first of several devices that will radically expand access to mobile phones. Meanwhile Apple’s top-of-the-line devices came with an incredible processor, the A7, which proved that mobile devices can approach the power of desktop-class PCs. I was blown away, too, by the growth of apps that are now rewiring our worlds—apps such as ride-sharing service Uber or the robotic slot-car racer Anki Drive, which show the potential for our phones to transform the physical world. As the analyst Benedict Evans has argued, the true revolution in mobile computing is one of scale; we’re going from an Internet controlled by PCs to one controlled by three billion to five billion phones. No device on the horizon—not the long-awaited TV made by Apple, not Google Glass, not a smartwatch—will be as exciting as what smartphones and tablets hold in store for us. So let’s stop yearning for new stuff just for novelty’s sake. The next big thing is already here, it’s in your pocket, and it’s incredible. Second, privacy is no longer an afterthought. I’ve already argued that the disappearing-message app Snapchat was the most interesting technology of 2013 because it paved the way for services that don’t save all our data by default. The larger message of Snapchat, though, is that privacy isn’t dead. For years, tech giants have given lip service to privacy. “It’s very important to us!” they insist while slurping up mountains of your data. But the industry hasn’t spent much time looking at privacy as a place for innovation, as a feature that users will care about when they choose apps or services. Thanks to Snapchat, revelations about the National Security Agency, and an increased fear of living in a panopticon, that will thankfully begin to change in 2014. Watch for an avalanche of apps that take privacy seriously—whether they delete data by default, keep your data local, or limit the scope of their sharing. Third, enterprise tech is interesting, finally. For years, business software was a dead-end for innovation, dominated as it was by Microsoft, MSFT +0.54% Oracle, ORCL +1.91% and other entrenched incumbents. Now that’s changing. In 2013 several alternatives rose to challenge old-school business tech—like Quip, a clever new word-processing app, or Box’s collaboration software, Box Notes—and I suspect this trend will continue this year. One enterprise advance I’m looking forward to: The rise of companies looking to bring cloud-based services to specific, specialized markets—also known as “vertical software-as-a-service” businesses. I’m talking about firms like Veeva Systems, VEEV -0.67% which makes a cloud-based sales tool for the health care industry, and which successfully went public in the fall. Watch for other startups aimed at specific industries—law firms, hospitality, health care—to get really big, without anyone noticing, in 2014. Last but not least, robots aren’t necessarily coming for your job. It’s been a cliché in the Valley for years that machines will replace humans across a wide variety of job types. But while artificial intelligence is still advancing at a furious pace, I was thrilled that AI is augmenting, rather than superseding, humans. Look how Redfin used tech to create better real-estate agents rather than replace them, or how the app Duolingocrowdsources human intelligence to produce better translations than machines are capable of. I think we’re witnessing the dawn of a new paradigm in machine-human cooperation: Combining machine intelligence with biological intelligence will always trump one or the other. Machines make us better, and we make machines better. There’s still hope for us. Welcome to the bionic future. Do you have any to add? I’d love to hear from you about the best and worst tech trends of the year.|It’s easy to get jaded when you cover the technology industry. Silicon Valley’s giants are constantly belching wisps of marshmallow-thick hype, and any reporter looking to cover the beat has to be constantly on guard against unproven claims about this or that algorithmically-abetted amazing advance. Dan Goldsmith Named Innovative Person by PM360 | https://www.veeva.com/media/dan-goldsmith-named-innovative-person-by-pm360/ | 2013-12-11|http://www.pm360online.com/innovators-people-2/?GTTabs=4 | | Dan Goldsmith, general manager, has been named an Innovative Person and a Data Management Master in PM360’s Innovations issue. Dan focuses his efforts on developing Veeva Network, Veeva’s most recent product offering and the industry’s first and only cloud-based customer data master solution combining data, software and stewardship services.|Dan Goldsmith, general manager, has been named an Innovative Person and a Data Management Master in PM360’s Innovations issue. Veeva Systems’ CEO on Why Pharma Needs his Cloud Software | https://www.veeva.com/media/veeva-systems-ceo-on-why-pharma-needs-his-cloud-software/ | 2013-11-06|http://www.forbes.com/sites/kerryadolan/2013/11/06/veeva-systems-ceo-on-why-pharma-needs-his-cloud-software/ | | FORBES – Peter Gassner has spent his career in the world of software and relational databases, working at IBM IBM and then PeopleSoft. He witnessed the promise of cloud software while working at Salesforce.com CRM. His vision, though, was to target an industry in need of specialized software housed in the cloud. So he left Salesforce and cofounded Veeva Systems in 2007, building software catered to pharmaceutical and life sciences firms.|Veeva Systems is at the heart of two explosive megatrends: the cloud and life sciences. So it should be no surprise that the company had little trouble with its IPO. In today’s trading, the shares are up a sizzling 80%. “It looks like you’re trying to use word on an iPad” | https://www.veeva.com/media/it-looks-like-youre-trying-to-use-word-on-an-ipad-2/ | 2013-10-31|http://www.businessweek.com/magazine/it-looks-like-youre-trying-to-use-word-on-an-ipad-01192012.html | | In this article from Bloomberg Businessweek, Matt Wallach is interviewed on iRep and the iPad’s importance to the global pharma industry.| Veeva CEO: ‘Customer Dissatisfaction is My Opportunity’ | https://www.veeva.com/media/veeva-ceo-customer-dissatisfaction-is-my-opportunity/ | 2013-10-23|http://www.forbes.com/sites/tomtaulli/2013/10/16/veeva-ceo-customer-dissatisfaction-is-my-opportunity/?partner=yahootix | | FORBES – Veeva Systems is at the heart of two explosive megatrends: the cloud and life sciences. So it should be no surprise that the company had little trouble with its IPO. In today’s trading, the shares are up a sizzling 80%. Yet Veeva has done something else that is remarkable: the company is not only growing quickly but is also profitable. In fact, the company has generated more operating cash flows – in the past year – then it has raised in overall funding.|Veeva Systems is at the heart of two explosive megatrends: the cloud and life sciences. So it should be no surprise that the company had little trouble with its IPO. In today’s trading, the shares are up a sizzling 80%. Veeva Systems CEO: We’re Focused on the Life Sciences | https://www.veeva.com/media/fox-business-veeva-systems-ceo-were-focused-on-the-life-sciences/ | 2013-10-22|http://video.foxbusiness.com/v/2759475063001/veeva-systems-ceo-were-focused-on-the-life-sciences/ | | Fox Business — Veeva Systems CEO Peter Gassner on the future of the cloud computing company.| Moving the Life Sciences Industry to the Cloud | https://www.veeva.com/media/bloomberg-moving-the-life-sciences-industry-to-the-cloud/ | 2013-10-21|http://www.bloomberg.com/video/moving-the-life-sciences-industry-to-the-cloud-u2qa~IVeT3Sg0eNe1CaG5g.html | | Bloomberg — Peter Gassner, co-founder and CEO of Veeva Systems, discusses the company’s cloud-based software for the global life sciences industry. He speaks with Cory Johnson on Bloomberg Television’s “Bloomberg West.” |Peter Gassner, co-founder and CEO of Veeva Systems, discusses the company’s cloud-based software for the global life sciences industry. He speaks with Cory Johnson on Bloomberg Television’s “Bloomberg West.” CNBC Squawk on the Street | https://www.veeva.com/media/cnbc-squawk-on-the-street/ | 2013-10-20| | | CNBC Squawk on the Street — “Veeva listing on the big board today, after pricing at $20 above the range, Peter Gassner is the CEO …” |CNBC — Veeva Systems may not get the sexy headlines of, say, a Twitter or Facebook, but it sure has investors’ attention. On Heels of Veeva Systems’ Mega IPO, a look at its Philly Ties and Vision for Life Sciences IT | https://www.veeva.com/media/it-looks-like-youre-trying-to-use-word-on-an-ipad/ | 2013-10-18|http://www.phillytechnews.net/2013/10/on-heels-of-veeva-systems-mega-ipo-look.html | | This article from Philly Tech News covers the Veeva IPO and the launch of Veeva Network.| Veeva Systems IPO Shows Updraft in Cloud Business | https://www.veeva.com/media/veeva-systems-ipo-shows-updraft-in-cloud-business/ | 2013-10-16|http://www.cnbc.com/id/101118773?__source=msn%7Cmoney%7Cheadline%7Cheadline%7Cstory%7C&par=msn | | CNBC — Veeva Systems may not get the sexy headlines of, say, a Twitter or Facebook, but it sure has investors’ attention. In its initial public offering Wednesday, the cloud-based software company saw its shares, which had been priced at $20, soar as high as $39.64. The stock closed at $37.16 a share. The Pleasanton, Calif.-based company is part of two major trends that investors can’t seem to get enough: 1) It’s a cloud service provider for life sciences companies, including big names such as Pfizer, Eli Lilly, and Novartis. 2) It has been profitable for the past three years and in the past year generated more operating cash flow than it raised in funding.|CNBC — Veeva Systems may not get the sexy headlines of, say, a Twitter or Facebook, but it sure has investors’ attention. Veeva CEO: We Were Never Going to Delay IPO | https://www.veeva.com/media/veeva-ceo-we-were-never-going-to-delay-ipo/ | 2013-10-16|http://finance.fortune.cnn.com/2013/10/16/veeva-ceo-we-were-never-going-to-delay-ipo/?source=yahoo_quote | | FORTUNE — Veeva Systems, a provider of cloud-based CRM and content management solutions for the life sciences industry, will begin trading shares on the NYSE today, after raising around $261 million in its IPO. The Pleasanton, Calif.-based priced its shares at $20 a piece, compared to an original target range of just $12-$14, and is now valued at more than $2.4 billion. I guess that’s what happens when your company not only is growing at more than 100% year-over-year, but also is profitable on just $10 million in VC funding.|FORTUNE — Veeva Systems, a provider of cloud-based CRM and content management solutions for the life sciences industry, will begin trading shares on the NYSE today, after raising around $261 million in its IPO. Veeva IPO Defies Jitters Over US economy | https://www.veeva.com/media/veeva-ipo-defies-jitters-over-u-s-economy/ | 2013-10-14|http://247wallst.com/apps-software/2013/10/16/veeva-ipo-defies-jitters-over-u-s-economy/ | | 24/7 Wall St — Veeva Systems Inc. (NYSE: VEEV), a California-based company that makes cloud software solutions for the life sciences industry, held its initial public offering (IPO) Wednesday morning among a swirl of uncertainty about the U.S. economy. Investors have put aside any worries, though, driving the stock to a more than 80% gain in the first hour of trading.| Veeva Systems Stock Soars on Debut | https://www.veeva.com/media/veeva-systems-stock-soars-on-debut/ | 2013-10-14|http://bigstory.ap.org/article/veeva-systems-stock-soars-debut | | AP – The Big Story — NEW YORK (AP) — Shares of Veeva Systems Inc. nearly doubled in their trading debut Wednesday after the cloud-based software company raised about $261 million in its initial public offering. Veeva Systems, which is based in Pleasanton, Calif., makes cloud software for pharmaceutical companies and other life science businesses that helps them manage customers and increase productivity. The programs are hosted on remote servers, often called the “cloud.” That means that businesses don’t need to install and run software in-house, saving on the costs of running their own hardware.| Veeva Systems Stock Soars on Debut | https://www.veeva.com/media/huffington-post-veeva-systems-stock-soars-on-debut/ | 2013-10-14|http://www.huffingtonpost.com/huff-wires/20131016/us–veeva-systems-ipo/?utm_hp_ref=media&ir=media | | Huffington Post — NEW YORK — NEW YORK (AP) — Shares of Veeva Systems Inc. are soaring in their trading debut Wednesday after the cloud-based software company raised about $261 million in its initial public offering.| Pharmaceutical Companies Finding Cloud Comfort Level | https://www.veeva.com/media/medcity-news-pharmaceutical-companies-finding-cloud-comfort-level/ | 2013-10-14|http://www.medcitynews.com/2013/10/pharmaceutical-companies-finding-cloud-comfort-level/ | | MedCity News — If any sector gets more flack for being slow to adopt innovative IT than healthcare, it’s the pharmaceutical industry. Yet, as companies have been forced to find new ways to streamline work flows and reduce costs, many are finding that some cloud-based tools could help. Cloud software solutions are taking on several different tasks in the pharmaceutical and medical device industry. It can mean improving the quality of data for sales forces and providing practical ways for clinical trial site managers to communicate across a wide geographic divide. It’s also making it easier for companies to merge without the problems that invariably arise when data between disparate computer systems is aggregated. But looking ahead, there are also some intriguing applications that involve combining the cloud with big data from public and private sources and applying analytics.| Eli Lilly’s Veeva Bags OPPI Sales Force Excellence Award 2013 | https://www.veeva.com/media/eli-lillys-veeva-bags-oppi-sales-force-excellence-award-2013/ | 2013-09-30|http://www.pharmabiz.com/NewsDetails.aspx?aid=77898&sid=2 | | PharmaBiz.com — To promote excellence in pharmaceutical selling in 2012, Eli Lilly and Company – India, the leading innovation based pharmaceutical player, has won the OPPI Sales Force Excellence Award 2013 for its project Veeva which aimed at delivering unparalleled customer experience by empowering the sales force.|To promote excellence in pharmaceutical selling in 2012, Eli Lilly and Company – India, the leading innovation based pharmaceutical player, has won the OPPI Sales Force Excellence Award 2013 for its project Veeva which aimed at delivering unparalleled customer experience by empowering the sales force. The Quiet Successes that Drive Silicon Valley | https://www.veeva.com/media/siliconvalley/ | 2013-08-16|http://finance.fortune.cnn.com/2013/08/13/the-quiet-successes-that-drive-silicon-valley/ | | FORTUNE — Salesforce.com recently announced the acquisition of EdgeSpring, an emerging player in the business intelligence/analytics market. It was an amazing outcome for the company’s two founders, employees and investors (Lightspeed and Kleiner Perkins). So why didn’t you hear about it? Because the founders want it that way. They represent Quiet Success. And – despite what you may have been led to believe – it happens every day in Silicon Valley.|Salesforce.com recently announced the acquisition of EdgeSpring, an emerging player in the business intelligence/analytics market. It was an amazing outcome for the company’s two founders, employees and investors (Lightspeed and Kleiner Perkins). Quarterbacking Multi-Channel Interactions | https://www.veeva.com/media/quarterbacking-multi-channel-interactions/ | 2013-08-12|http://www.pm360online.com/quarterbacking-multi-channel-interactions/ | | It’s the fourth quarter, a tie game with 45 seconds left on the clock and third down. Suddenly, the defense blitzes the quarterback. Does he pass downfield or carry the ball? Does he stick with the play or change directions and hand-off? Only the quarterback can make this game-time decision. He is the only player who can see the entire field, and therefore, who has all of the information needed to coordinate the best course of action by picking from a variety of plays. But in the pharmaceutical industry, the sales rep—the quarterback of the customer relationship—doesn’t have a full view of the field. He only has partial visibility, seeing just a slice of the customer interactions. These reps rarely see the interactions that marketing, for example, has with a customer—and vice versa.|It’s the fourth quarter, a tie game with 45 seconds left on the clock and third down. Suddenly, the defense blitzes the quarterback. Does he pass downfield or carry the ball? Does he stick with the play or change directions and hand-off? Sunshine Act open payment requirements to spur cloud-provider growth and M&A interest | https://www.veeva.com/media/sunshine-act/ | 2013-08-01|http://www.ft.com/cms/s/2/4663f4da-f926-11e2-a6ef-00144feabdc0.html#axzz2aXblC21M | | Cloud-based healthcare provider (HCP) data service companies are expected to see a jump in business growth as well as M&A, investor and partnership interest because of new open payment rules under the US Sunshine Act, experts told BioPharm Insight. The legislation – otherwise known as the Physician Payments Sunshine Act – is set to come into force on 1 August 2013. It requires pharmaceutical and medical device companies to publicly list all payments to or money spent on physicians and other HCPs greater than USD 10. The information will be available on the public database Centers for Medicare & Medicaid Services (CMS). Failure to comply could lead to charges of up to USD 100,000 per incidence.| Veeva Buys AdvantageMS, Building Out its Foundation for Healthcare-Provider Master Data | https://www.veeva.com/media/healthcare-provider-master-data/ | 2013-07-15|http://pharmaceuticalcommerce.com/index.php?pg=latest_news&articleid=26906&keyword=Veeva-AdvantageMS-Goldsmith-CRM-master%20data | | Acquisition brings millions of provider listings into the Veeva Network, along with validation services and territory-alignment software. Veeva (Pleasanton, CA), a leading CRM vendor serving the life sciences industry exclusively, has followed through on the promise it made at its annual customer meeting in May, buying AdvantageMS (Fort Washington, PA) for an undisclosed sum. The company had announced Veeva Network at that meeting, which will include master-data management and compliance services when it goes live later this year. When Veeva announced this service, it said that the Network will be enhanced by pooling (pending client approval) the HCP data of the customers of its CRM solutions.|Acquisition brings millions of provider listings into the Veeva Network, along with validation services and territory-alignment software. After 42 Years…Email Finally Clicks in the Pharmaceutical Industry | https://www.veeva.com/media/email-in-the-pharma-industry/ | 2013-06-26|http://www.drugs.com/news/after-42-years-email-finally-clicks-pharmaceutical-industry-45501.html | | After just four-plus decades, email has finally clicked in the pharmaceutical industry – and not a moment too soon. As technology advances allow life science companies to evolve their communications strategies with compliant email, sales reps can now increase and improve the quality of customer interactions, reach more low-access healthcare practitioners globally and deliver more relevant drug information — all without increasing the size of the sales force.|Top 10 Ways to Secure a Competitive Edge with Compliant Email Communications. After just four-plus decades, email has finally clicked in the pharmaceutical industry – and not a moment too soon. iPad vs. Windows 8 Surface: Which is Better for Pharma? | https://www.veeva.com/media/pharma-ipad-windows-8/ | 2013-06-25|http://www.pm360online.com/ipad-vs-windows-8-surface-which-is-better-for-pharma/ | | The iPad vs. the Surface Pro. iOS vs. Windows 8. Apple vs. Microsoft. Have these two tech heavyweights elicited an internal debate within pharma companies over which device is better for their sales teams or is the choice a foregone conclusion? After all, pharma has already heavily adopted the iPad and they are not alone. On the vendor-side, Veeva Systems, a leader in cloud-based software for the global life sciences industry, recently released their CLM and CRM mobile offerings for Windows 8, after already having the offerings available for iOS devices. Their goal was to accommodate the client no matter their preference. “A number of our customers have started to explore the move to a single device and are evaluating the potential impact to their businesses,” says Paul Shawah, VP of Commercial Strategy for Veeva Systems. “But whether or not this is the right move depends entirely on each organization. The benefits and trade-offs are specific to their unique needs and environments.”| Veeva Introduces CRM for Windows 8, Protected E-mail Service and a Bid for Master-Data Management | https://www.veeva.com/media/veeva-introduces-crm-for-windows-8-protected-e-mail-service-and-a-bid-for-master-data-management/ | 2013-05-10|http://www.pharmaceuticalcommerce.com/index.php?pg=latest_news&articleid=26860&keyword= | | Veeva (Pleasanton, CA), which originated the popular cloud-based CRM and iRep platforms for life sciences field sales forces several years ago, has upped the ante with its rollout of a set of new products and business services, announced at its annual users group meeting (Philadelphia, May 6-8).| California-Based Cloud Pharma CRM & CMS Vendor Veeva Systems May Seek IPO | https://www.veeva.com/media/california-based-cloud-pharma-crm-cms-vendor-veeva-systems-may-seek-ipo-2/ | 2013-03-14|http://www.phillytechnews.net/2013/03/california-based-cloud-pharma-crm-cms.html | | Veeva Systems, a cloud CRM and CMS vendor that has rapidly emerged as a leader in serving the pharmaceutical industry, may be considering an IPO, according to a Bloomberg report.| Into the Cloud: New Technology Blowing in Big Benefits to Regulated Content Management in Life Sciences | https://www.veeva.com/media/into-the-cloud-new-technology-blowing-in-big-benefits-to-regulated-content-management-in-life-sciences/ | 2013-03-04|/wp-content/uploads/2013/05/Advise-February-2013-Global-Forum-2.pdf | | For more than two decades, life sciences organizations have purchased, configured and deployed a series of ever-expanding and complex content management systems. These tools continue to tack on new capabilities, but they have failed to fundamentally change to meet the new business challenges facing the life sciences market: greater collaboration, fast-paced globalization, increasing compliance and a stronger focus on cost reduction. Cloud computing may be the key. Read how the cloud enables life sciences companies to meet the needs of the current business climate: to collaborate closely, connect globally, comply swiftly and manage costs effectively.| B2B Investor Gordon Ritter Excited by VC Market’s Pivot | https://www.veeva.com/media/b2b-investor-gordon-ritter-vc-markets-pivot/ | 2013-02-26|http://m.bizjournals.com/sanjose/news/2013/02/25/b2b-investor-gordon-ritter-excited-by.html?r=full | | This will be the year of the enterprise. Enterprise application and infrastructure companies are the most popular and powerful business models that the public markets are going to see this year.| Vertical is the New Horizontal: How the Cloud Makes Domain Expertise More Valuable in the Enterprise | https://www.veeva.com/media/vertical-is-the-new-horizontal-how-the-cloud-makes-domain-expertise-more-valuable-in-the-enterprise/ | 2012-07-30|http://techcrunch.com/2012/07/28/vertical-is-the-new-horizontal-how-the-cloud-makes-domain-expertise-more-valuable-in-the-enterprise/ | | In the days before the cloud, on-premise software providers that focused on selling into a vertical market were considered second-class citizens to the “big guns” selling into the broader horizontal marketplace. The real “win”—in market share, wallet share and ultimately, profits—was the broadest approach. The notion of specializing in solutions that serve a market niche or specific industry was considered limited unless it was just the start of something more horizontal. However, with the advent of the SaaS model, the tables have turned. Focusing on niche verticals or specific functional areas may be one of the most successful strategies of the enterprise cloud software era.| Veeva Named to Business Insider’s List of 25 Next Big Enterprise Startups | https://www.veeva.com/media/veeva-named-to-business-insiders-list-of-25-next-big-enterprise-startups/ | 2012-07-26|http://www.businessinsider.com/the-hottest-enterprise-startups-that-venture-capitals-say-they-love-2012-7#veeva-systems-giving-a-regulated-industry-a-great-cloud-service-22 | | If there’s one crowd of people who know about hot startups, it’s the venture capitalists who fund them. Read this article to review the results of Business Insider’s informal survey of a handful of top enterprise VCs to find out which startups they are most excited about.| Cloud Rains Startups | https://www.veeva.com/media/cloud-rains-startups/ | 2012-07-10|/wp-content/uploads/2012/07/SanFranciscoBT_Cloud_Rains_Startups.pdf | | Companies float high on Salesforce technology as salesforce.com makes space on it’s cloud. Read this article about leading organizations – including Veeva – that use Force.com technology to help make their solutions successful.| Did Veeva Vault Just Make Regulated Content Management Systems Sexy? | https://www.veeva.com/media/did-veeva-vault-just-make-regulated-content-management-systems-sexy-2/ | 2012-07-06|http://www.cmswire.com/cms/customer-experience/did-veeva-vault-just-make-regulated-content-management-systems-sexy-016417.php | | Content Management Systems at Life Sciences companies typically don’t have many fans and are rarely seen as beautiful. Veeva Systems is out to change that. Regulatory CMSs in the Life Sciences Industry are seen as an ugly, but necessary, evil because without them companies can’t bring new drugs to market, comply with FDA and ICH regulations, or minimize their chances of going to jail for non-compliance. That being said, why would a hot, happening software company, like five-year old Veeva Systems, and a group of seasoned Regulatory Life Sciences and Web CMS/CRM experts want to enter that business? Read on to find out!| mHealth + HTML5 = Pharma in 2012 | https://www.veeva.com/media/mhealth-html5-pharma-in-2012/ | 2012-03-20|/wp-content/uploads/2012/03/mHealth-+-HTML5pharma-in-2012-Full-Article.pdf | | The technology is already in place; now pharma marketers will focus on enhancing behavioral integration and improving a patient’s mHealth experiences in 2012. Hear what Matt Wallach, Veeva co-founder and chief strategy officer and Jennifer Goldsmith, vice president, Veeva Vault have to say in this insightful article.| Veeva Adds Sample and Promotion Ordering to its Cloud-Based CRM | https://www.veeva.com/media/veeva-adds-sample-and-promotion-ordering-to-its-cloud-based-crm/ | 2012-03-01|http://www.pharmaceuticalcommerce.com/index.php?pg=top_news&articleid=26488&keyword=Veeva-CRM-cloud-iPad-Shawah | | Announces more contract wins; integration with other software platforms in sales force automation To hear Veeva’s VP of product marketing, Paul Shawah, tell it, Veeva (Pleasanton, CA) is now in a position to deliver a steady stream of enhancements, based mostly on customer demand and the attention span of its programmers. The latest: sample and promotional item ordering. “We already have such sample-management functions as electronic signature capture and inventory management; now sales reps can put in orders directly from Veeva CRM, and avoid the inconvenience of going to a sample-ordering portal and rekeying data,” he says. […]| As Business Software Moves to Cloud, Emergence Capital Closes Third Fund at $250M | https://www.veeva.com/media/as-business-software-moves-to-cloud-emergence-capital-closes-third-fund-at-250m/ | 2012-03-01|http://blogs.wsj.com/venturecapital/2012/02/29/as-business-software-moves-to-cloud-emergence-capital-closes-third-fund-at-250m/ | | Ten years ago, the founders of San Mateo, Calif.-based venture firm Emergence Capital Partners made a bet that business software would move to the cloud. Instead of loading software onto local machines, the firm figured, businesses and their employees would access it through a Web browser and get automatic updates sent from outside servers. And instead of paying for it in one big chunk, businesses would pay a monthly fee and could cancel the obligation at any time […]| iPad helps Apple Succeed in Business World | https://www.veeva.com/media/ipad-helps-apple-succeed-in-business-world/ | 2012-02-07|http://www.sfgate.com/cgi-bin/article.cgi?f=/c/a/2012/02/01/BUJ61N0VBN.DTL | | Even as Amazon’s Kindle Fire and other tablets play catch-up in the consumer market, the iPad faces little competition among corporations such as financial services and pharmaceutical firms. Apple’s iPhone, meanwhile, is the top-selling smart phone, forcing businesses to accommodate workers who use it. That has helped set the stage for Apple’s Mac computer to make its own inroads in the corporate world. “We haven’t seen a single pharma deploy on anything but the iPad,” said Matt Wallach, co-founder of Veeva Systems, a Pleasanton maker of sales software for drug companies. “I’ve seen a lot of devices come and go over the years. Nothing touches the speed of adoption of the iPad.”| Apple Infiltrates $3.8 Trillion Market with iPad: Tech | https://www.veeva.com/media/apple-infiltrates-3-8-trillion-market-with-ipad-tech/ | 2012-02-06|http://www.bloomberg.com/news/2012-02-01/apple-invades-3-8t-workplace-market-with-ipad.html | | Apple Inc. (AAPL), without much effort on its part, is making rapid headway in selling to corporations. After years of being the also-ran to Microsoft Corp. (MSFT) in the workplace, Apple has seen its iPad become a standard business tool. “We haven’t seen a single pharma deploy on anything but the iPad,” said Matt Wallach, co-founder of Veeva Systems Inc., a Pleasanton, California-based maker of sales software for drug companies. “I’ve seen a lot of devices come and go over the years. Nothing touches the speed of adoption of the iPad.”| RIM’s New CEO is Staying the Course | https://www.veeva.com/media/rims-new-ceo-is-staying-the-course/ | 2012-01-27|http://www.businessweek.com/magazine/rims-new-ceo-is-staying-the-course-01262012.html | | In this article, Bloomberg Businessweek turns the spotlight on how Apple’s iPad has dominated the first major new corporate hardware market in years. Veeva’s Matt Wallach comments on the rapid uptake of the iPad among 95% of Veeva customers, and how “The iPad’s success in the enterprise means that RIM is dead, at least in pharma.”| Veeva CRM Now Integrated with Concur and Group DCA | https://www.veeva.com/media/veeva-integrates-crm-system-with-concur-and-group-dca/ | 2012-01-05|http://www.destinationcrm.com/Articles/CRM-News/Daily-News/Veeva-Integrates-CRM-System-with-Concur-79725.aspx | | Integration is the key word in this article highlighting Veeva’s recent announcements on our seamless interactions with Concur for expense management and Group DCA for Digital Detailing.| Leading Pharma Company Employs Veeva CRM for Enterprise-Wide Deployment | https://www.veeva.com/media/leading-pharma-company-employs-veeva-crm-for-enterprise-wide-deployment/ | 2011-12-01|http://outbound-call-center.tmcnet.com/topics/outbound-call-center/articles/73244-leading-pharmaceutical-company-employs-veeva-crm-enterprise-wide.htm | | Seeking a single solution that would connect their entire US sales organization, this newly merged top 10 pharma company selects Veeva CRM citing Veeva’s multitenant SaaS architecture, flexibility, low cost and easy integration as key differentiators. Veeva CRM provides the perfect fit functionally and the most cost effective solution.| Cut the Cord & Take to the Cloud | https://www.veeva.com/media/cut-the-cord-take-to-the-cloud/ | 2011-12-01|/wp-content/uploads/2011/12/rep21691067_pe_ePrint_LR.pdf | | While cloud computing might be the catchphrase of the moment, not all systems are created equal. A feature that should be considered when looking for a new software-as-a-service (SaaS) system is multitenancy which is a chief characteristic of a mature cloud computing application. Matt Wallach discusses this important distinction in this article.| Software as a Service Gaining Traction | https://www.veeva.com/media/software-as-a-service-gaining-traction/ | 2011-12-01|/wp-content/uploads/2011/12/PharmaVOICE0410_SaaS.pdf | | As industries around the world increase SaaS use, pharmaceutical companies are following suit. Experts discuss the growing use of SaaS in the industry and offer predictions for future applications.| True SaaS Transforms Sales Automation Systems to Make Upgrades Painless | https://www.veeva.com/media/true-saas-transforms-sales-automation-systems-to-make-upgrades-painless/ | 2011-12-01|http://www.pharmaceuticalcommerce.com/frontEnd/1427-Veeva_CRM_SFA_SaaS_Wallach_pharma.html | | Multitenant sales force automation (SFA) systems are coping with an increasingly complex regulatory environment necessitating flexible and cost effective solutions. Only a true multitenant SaaS solution can cost-effectively support the constantly shifting, complex regulatory environment facing today’s life sciences companies.| Veeva Systems Launches Industry’s First SaaS CRM Application Network | https://www.veeva.com/media/veeva-systems-launches-industrys-first-saas-crm-application-network/ | 2011-12-01|http://outbound-call-center.tmcnet.com/topics/hosted-call-center/articles/84987-veeva-systems-launches-simple-cost-effective-life-science.htm | | Extending the use and reach of Veeva CRM, Veeva Web removes the cost and complexity of system integration. Veeva Web is a prime example of the business value that a mature multitenant architecture can deliver, going beyond the “connector” approach to system integration delivering truly joint solutions that span multiple product areas.| Weathering the Compliance Storm | https://www.veeva.com/media/weathering-the-compliance-storm/ | 2011-12-01|http://pharmexec.findpharma.com/pharmexec/article/articleDetail.jsp?id=670570&sk=&date=&&pageID=1 | | Compliance concerns mount in the midst of constantly changing regulations. The majority of CRM systems are simply not built to weather this kind of change. Only SaaS CRM applications based on the cloud-computing model are uniquely designed to be able to change as frequently as regulations change providing pharma the necessary umbrella to weather any compliance storm.| Tickets.com, Others Follow Google, Amazon Lead in Opening Up | https://www.veeva.com/media/tickets-com-others-follow-google-amazon-lead-in-opening-up/ | 2011-12-01|http://www.pcworld.com/businesscenter/article/203208/ticketscom_others_follow_google_amazon_lead_in_opening_up.html | | More and more cloud computing companies are opening their doors to outside developers and are reaping the benefits, not only in revenue but also in watching their platform grow in ways they never imagined.| Veeva, Salesforce.com Tighten Pairing to Target Pharma, Biotech | https://www.veeva.com/media/veeva-salesforce-com-tighten-pairing-to-target-pharma-biotech/ | 2011-12-01|http://www.crn.com/news/cloud/227900057/veeva-salesforce-com-tighten-pairing-to-target-pharma-biotech.htm;jsessionid=SDrB9A34xrTmsWl45vRasg**.ecappj03 | | Find out why Veeva’s enhanced partnership with salesforce.com can help bring more pharmaceutical companies into the cloud.| CRM in the Cloud | https://www.veeva.com/media/crm-in-the-cloud/ | 2011-12-01|http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20101124/#/8/OnePage | | Dan Goldsmith of Veeva Europe explains why multitenant SaaS technology — or cloud technology — is becoming the glue that enables life science businesses to remain close to patients, prescribers and payers and to do so more cost-effectively than ever before.| Reps of Tomorrow Will Need Both Sciences & CRM Skills | https://www.veeva.com/media/reps-of-tomorrow-will-need-both-sciences-crm-skills/ | 2011-12-01|http://viewer.zmags.com/publication/d5bfcc6f#/d5bfcc6f/102 | | Future sales models will require reps to vary their roles beyond the current basic product knowledge and promotional messaging. Veeva’s Dan Goldsmith and Matt Wallach weigh in on the topic.| iRep Lets Docs Sign an iPad for Samples | https://www.veeva.com/media/irep-lets-docs-sign-an-ipad-for-samples/ | 2011-12-01|http://www.mmm-online.com/irep-lets-docs-sign-an-ipad-for-samples/article/194504/ | | iRep continues to get great press. This article talks about why the product is so innovative and how the industry is responding to the launch.| Veeva Systems Unveils Content Management Solution for Life Sciences | https://www.veeva.com/media/veeva-systems-unveils-content-management-solution-for-life-sciences/ | 2011-12-01|http://itsoftware.pharmaceutical-business-review.com/news/veeva-systems-unveils-content-management-solution-for-life-sciences-160211 | | Pharmaceutical Business Review writes about Veeva’s ground-breaking new product, Veeva Vault.| Cloud-Based IT Offering Manages Control of Marketing & Education Documents | https://www.veeva.com/media/cloud-based-it-offering-manages-control-of-marketing-education-documents/ | 2011-12-01|http://www.pharmaceuticalcommerce.com/frontEnd/main.php?idSeccion=1605 | | Pharmaceutical Commerce interviewed Veeva Vice President, Jennifer Goldsmith on Veeva Vault, our latest cloud offering for the life sciences industry.| A Decade of Change | https://www.veeva.com/media/a-decade-of-change/ | 2011-12-01|http://viewer.zmags.com/publication/01bf29e7#/01bf29e7/34 | | All in all, the decade can be defined as one of tremendous change – and it’s not expected to end any time soon. In the March issue of PharmaVOICE, Veeva Systems’ Chief Strategy Officer, Matt Wallach, along with industry experts review the top 10 game changes of the past decade and set the stage for what pharma can expect heading into the next decade. Business as usual is only true if one defines “usual” as “change”.| Veeva Launches First iPad CRM/CLM Cloud Application | https://www.veeva.com/media/veeva-launches-first-ipad-crmclm-cloud-application/ | 2011-12-01|http://call-center-software.tmcnet.com/topics/call-center-software/articles/167966-veeva-launches-first-ipad-crmclm-cloud-application.htm | | Apple’s recent upgrades to the ever popular iPad seem to create endless possibilities for life sciences companies using Veeva Systems’ new iRep. iRep, the first CRM+CLM application for life sciences designed specifically for the iPad, is yet another innovative product from Veeva which recently expanded its partnership with salesforce.com to accelerate the delivery of Veeva CRM applications to the global pharmaceutical and biotechnology industry.| What the Cloud Can Do for You | https://www.veeva.com/media/what-the-cloud-can-do-for-you/ | 2011-12-01|/wp-content/uploads/2011/12/What_the_cloud_can_do_for_you_PharmRep0411.pdf | | Type “cloud” into Google and you’ll get some 480 million hits, but what can it really do for sales reps? The April 2011 issue of Pharmaceutical Representative features a story by Veeva founder Matt Wallach that outlines 10 ways that the cloud can help pharma reps do their jobs even better.| Industry Experts Challenge the Status Quo on Content Management | https://www.veeva.com/media/industry-experts-challenge-the-status-quo-on-content-management/ | 2011-12-01|/wp-content/uploads/2011/12/thefutureofregulatedcontentmanagement.pdf | | As seen in PharmaVOICE magazine, Veeva gathers five life sciences industry experts from top pharmaceutical and consulting companies to debate the past and future of regulated content management systems. Read as these industry experts discuss the need for companies’ business technologies to catch up to their rapidly changing industry.| Effective CRM in China: A Large & Moving Target | https://www.veeva.com/media/effective-crm-in-china-a-large-moving-target/ | 2011-12-01|/wp-content/uploads/2011/12/MedAdNews-Effective-CRM-in-China.pdf | | As multinational pharmaceutical companies execute their strategies for growth in China, they are well advised to take a fresh and different approach to customer relationship management, advises Cindy Zhang of Veeva China.| Veeva to Hire 50 as Drug, Device Companies Head to the Cloud | https://www.veeva.com/media/veeva-to-hire-50-as-drug-device-companies-head-to-the-cloud/ | 2011-12-01|http://www.bizjournals.com/sanfrancisco/blog/biotech/2011/08/veeva-salesforce-crm-cloud-computing.html | | Veeva Systems is taking drug companies into the cloud and facing down big-name players like Oracle Corp.| Veeva, ZS Associates Partner to Combine SFA Services | https://www.veeva.com/media/veeva-zs-associates-partner-to-combine-sfa-services/ | 2011-12-01|http://www.pharmaceuticalcommerce.com/frontEnd/1723-Veeva_ZS_Publicis_SFA_Keefer.html | | Veeva Systems and ZS Associates partner together to provide life sciences companies with an automated, end-to-end solution that greatly streamlines sales processes.| Relationship Building | https://www.veeva.com/media/relationship-building/ | 2011-12-01|http://viewer.zmags.com/publication/7e0af12c#/7e0af12c/102 | | Paul Shawah, VP, Multichannel Strategy, comments on how sales reps can make face-to-face interactions with physicians as meaningful as possible.| Building a Culture of Innovation | https://www.veeva.com/media/building-a-culture-of-innovation/ | 2011-11-27|http://viewer.zmags.com/publication/7e0af12c#/7e0af12c/36 | | Jen Goldsmith, VP, Veeva Vault, comments in this article on pharmaceutical R&D. Under pressure to counter rising costs, depleted pipelines and impending patent expiries, the industry is facing not only a productivity crisis but also a crisis in innovation.|